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p. 24 second paragraph. This should read: When the Bx field is uniform the
signal received by the coil from the sample lying in the uniform part of the
Bi field, immediately after a 90° pulse, is proportional to both the number of
nuclei in the sample and the sample volume. This can be expressed by the
following equation:
p. 206. The reference Helpern et al., 1987, is not printed in the correct
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The work presented in this thesis involves new methods of using nuclear
magnetic resonance spectroscopy (NMR) to study ion transport in vivo
in hypertension.
A new NMR technique was developed which allowed measurement of
absolute concentrations of rubidium (potassium) in vivo. This method
was used to study rubidium (potassium ) kinetics in spontaneously hyper¬
tensive rats (SHRs) and Wistar-Kyoto (WKY) rats and showed evidence
for increased potassium efflux and increased Na+/K+-ATPase activity in
SHR skeletal muscle in vivo.
NMR was also used to study in vivo Na+/H+ antiporter activity in the
skeletal muscle of the rat and it was found that Na+/H+ antiporter activ¬
ity is increased by ^-adrenoceptor stimulation and by increasing the
activity of the sympathetic nervous system. This stimulation of Na+/H+
antiporter activity in skeletal muscle by the sympathetic nervous system
may be part of the well known but poorly understood "fright and flight"
mechanism.
Using these new NMR techniques it was found that Na+/H+ antiporter
activity is increased in SHR skeletal muscle in vivo. In addition, this dif¬
ference in antiport activity can be removed by blocking L-type calcium
channels.
These differences in ion transport in SHRs occured in association with
increased skeletal muscle relaxation following contraction which is
similar to the finding in vascular smooth muscle in essential
hypertension.
Despite differences in in vivo Na+/H+ antiporter activity and in vivo
potassium fluxes in SHRs no difference was found in either intracellular
steady-state concentrations of potassium ions, hydrogen ions or
bicarbonate. In addition, there was no difference in intrinsic cell
buffering in SHRs in vivo compared with WKY rats.
On the basis of these findings a new hypothesis is proposed which links
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In this chapter I will review some aspects of ion transport in cells. I
will concentrate on control of ion transport in relation to cell volume
and pH regulation which are relevant to much of the work that will be
presented in the following chapters and I believe relevant to ion
transport abnormalities found in hypertension. I will then give a brief
outline of some of the common ion transport abnormalities found in
genetic hypertension and the problems that have been reported in in
vitro methods of studying ion transport. I will finish this chapter by
outlining the main aims of this project
1.1 SOME ASPECTS OF CELL VOLUME AND pH
REGULATION
1.11 Cell volume regulation
Regulation of cell volume is an essential requirement for every cell. As
the cell membrane is freely permeable to water, the volume of the cell
is determined by the number of osmotically active particles in the cell.
In all cells intracellular ions rather than cellular proteins are responsi¬
ble for the majority of the cell's osmotic potential (for a review see
Sten -Knudsen, 1978) and, therefore, every cell has to be able to keep
the concentration of these osmotically active ions constant. The two
most important osmotically-active cations are sodium and potassium.
Thus, control of the movement of these cations across the cell
membrane is critical for cell volume regulation.
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In contrast, calcium does not contribute directly to the cell osmotic
potential since the majority of calcium in the cell is bound (Postnov and
Orlov; 1985; Brostrom and Brostrom, 1990). The role of calcium in
cell volume regulation is more complex. Calcium may act as a second
messenger (Metcalfe et al., 1986; for a review see Bolton 1979),
controlling the opening and activation of sodium and potassium
membrane transporters which are important for volume regulation.
As there is a continuous tendency for the cell to loose potassium and to
a lesser extent gain sodium the cell has devised ways of keeping the
concentrations of these ions constant (Sten-Knudsen, 1978; Leaf, 1957).
As the maintenance of a high intracellular potassium and a low intracel¬
lular sodium occurs against the concentration gradients for these ions,
this is also an energy-dependent process. The membrane transporter re¬
sponsible for these gradients is the Na+-pump , Na+/K+-ATPase (E.C.
3.6.1.37), which transports 3 intracellular Na+ions for 2 extracellular
K+ions (Garrahan and Garay, 1974). This important membrane trans¬
porter is present in the membrane of nearly all eukaryotic cells and its
activity is carefully regulated (for a review see Schwartz et ah,1975).
In addition to maintaining constant concentrations of sodium and
potassium and a constant cell volume under resting conditions, cells
have the ability to restore there volume when this is artificially altered
in vitro, when they are placed in either a hypo- or hyper- osmolar
external environment. The cell is very sensitive to changes in volume
and mechanisms restoring volume back to normal can be triggered by
volume changes of less than 5% (Hudson and Schultz, 1988). The cell
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responds to a cell volume decrease by activating processes which
increase intracellular sodium resulting in a regulatory cell volume
increase (RVI), and to a cell volume increase by activating processes
which reduce intracellular potassium resulting in a regulatory volume
decrease (RVD)(for a review see Hoffman and Simonsen, 1989).
These volume regulatory mechanisms do not change the membrane
potential because movements of ions across the cell membrane are
balanced by the exchange of another ion, for example, the Na+/H+
antiport exchanges an external sodium ion for an intracellular proton,
with no change in the membrane potential.
The ion transporters involved in cell regulatory volume increase are
the Na+/H+antiport and the bicarbonate/chloride exchanger (Fig. la). A
combination of increased Na+/H+ exchange and bicarbonate/chloride
exchange results in an increase in the total concentration of cell Na+
with a resultant increase in cell osmotic potential and so an increase in
total cell water with cell swelling. A change in the intracellular pH is
prevented by release of protons from intracellular buffers.
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(b)
hf[H*-] [Cell Buffers] CI
I [ K+]
Fig. 1.1 Mechanisms regulating cell volume resulting in (a) a regulatory
cell volume increase and (b) a regulatory cell volume decrease.
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The ion transporters involved in a regulatory volume decrease include
potassium and chloride channels and also the bicarbonate/chloride
exchanger (Fig. lb). Increased opening of potassium and chloride
channels with increased potassium and chloride efflux and increased
bicarbonate/chloride exchange decreases intracellular potassium with a
resultant decrease in cell osmotic potential and a cell volume reduction.
The loss of potassium from the cell is greater than chloride because of
bicarbonate/ chloride exchange and the resultant increase in hydrogen
ion concentration is buffered by intracellular buffers.
The mechanism responsible for RVI is largely unknown but may
involve a change to the cytoskeleton of the cell. However, there are
many compounds that activate Na+/H+ exchange, including cell
mitogens (for a review see Grinstein, 1986) and any of these substances
have the potential for increasing cell volume. The mechanism
responsible for a RVD is also unknown but calcium has been implicated
in RVD at least in some cells (for reviews see Hoffman and Simonsen,
1989 and Schwartz and Passow, 1983).
The changes described above following a change in the osmolality of
the extracellular fluid bathing the cell does not arise in vivo because the
external environment of the cell is constant. However, the above mech¬
anisms of regulating volume will be activated in vivo in situations
where an external stimulus changes potassium or sodium fluxes across
the cell membrane altering the osmotic potential of the cell (Hoffman
and Simonsen, 1989). This will be discussed later in Chapter 10 in
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relation to vascular smooth muscle cell stimulation to contraction with
agonists such as angiotensin II or noradrenaline.
To conclude, cell volume regulatory mechanisms, in conjunction with
Na+/K+-ATPase, are important in vivo for maintaining intracellular
sodium and potassium ion concentrations following exposure to
substances that have a tendency to change the intracellular
concentrations of these ions and alter the osmotic potential of the cell.
1.12 Cell pH regulation
In the above section I briefly discussed the mechanisms by which cells
regulate their volume. It is clear that these processes are also related to
the control of pH in the cell.
In Figure 1.2 I have outlined some of the important mechanisms by
which a cell regulates intracellular pH. Regulation of intracellular pH
like regulation of cell volume is essential for cell survival. For a re¬
view of the cellular processes altered by a change in intracellular pH
see Busa and Nuccetelli (1984).
These mechanisms maintain the intracellular pH of the cell about 1.5
pH units above that pH that would be determined by passive diffusion
of hydrogen ions across the cell membrane (Roos and Boron, 1981).
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Fig. 1.2 Mechanisms involved in determining intracellular pH (a)
Na+/H+ antiporter (b) sodium-dependent bicarbonate/chloride exchange
(c) sodium-independent bicarbonate/chloride exchange (d) intracellular
buffers eg. cellular proteins, inorganic phosphate and in muscle phos-
phocreatine. (e) lactate monocarboxylate carrier which exchanges one
molecule of intracellular lactate for an extracellular hydroxyl ion. (f)
passive lactate efflux (g) acid production represented by {lactate. At
steady-state intracellular pH, acid production and acid influx will be
balanced by the acid efflux mechanisms shown above (a-f). During
contraction of muscle the most important mechanisms of acid efflux are




The Na+/H+ antiporter is one of the most important mechanisms for
controlling intracellular pH, and it does this by exchanging
extracellular Na+ ions for intracellular H+ ions with a stoichiometry of
1:1, with kinetics suggesting a single binding site for both sodium and
hydrogen ions. (Grinstein and Rothstein, 1986). The Km for
extracellular sodium is around 6 mmol/1 and so at normal
physiological concentrations of extracellular sodium the antiporter is
saturated for sodium and so Na+/H+ exchange is regulated by
intracellular hydrogen ion concentrations. There is also some evidence
that intracellular protons also act as allosteric modifiers of the Na+/H+
antiport (Aronson et al., 1982). The Km for hydrogen ions varies
depending on the cell investigated (Frelin et al., 1986) ranging from pH
6.3 to pH 7.4. In skeletal muscle the Km of the exchanger is 6.9 x 10"8
M, equivalent to a pH of 7.16 (Vigne et al., 1985). External H+ ions can
act as competitive (Aronson, 1985) and non-competitive inhibitors
(Vigne et al., 1982) of external Na+ ions, depending on the cell type,
which in the latter case can alter antiporter activity within the
physiological range of external pH .
The Na+/H+ antiport is reversibly inhibited by amiloride and amiloride
derivatives (Frelin et al., 1987). The antiport can be activated by vari¬
ous substances including cell mitogens (for a review see Grinstein et
al., 1989). This activation of the Na+/H+ antiporter is due to a shift in
the Km of the antiporter by 0.2-0.3 pH units. At a molecular level the
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antiport is activated by kinases including protein kinase C (for a review
see Aronson and Boron, 1986).
Whether the antiporter controls pH or results in a regulatory volume
increase, as discussed above, depends to some extent on the buffering
capacity of the cell. In the hypothetical situation where the buffering
capacity is infinite, the aniport will never reach equilibrium and will
continue to transport Na+ions into the cell and so will act entirely as a
volume regulator. If on the other hand there is no buffering capacity
then the antiporter will reach equilibrium very quickly and not change
the total osmotic potential of the cell. In vivo the situation lies between
these two extremes and so the antiporter acts as both a cell volume and
a pH regulator
1.122 Sodium-dependent and -independent bicarbonate!chloride ex¬
change
In skeletal and vascular smooth muscle the bicarbonate/chloride ex¬
changers can result in both bicarbonate influx and efflux. In these tis¬
sues the operation of the sodium-independent bicarbonate/chloride ex¬
changer results in a net chloride influx in exchange for intracellular bi¬
carbonate, resulting in intracellular acidification. This occurs because
the chemical concentration gradient for chloride predominates over
that of bicarbonate. However, during acidification of the cell there is a
reversal of the direction of bicarbonate flux with a sodium-dependent
influx of bicarbonate in exchange for intracellular chloride, resulting
in intracellular alkalinization (for a review see Cala and Grinstein,
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1988). In experiments using ammonium chloride to load the skeletal
muscle cell with acid, bicarbonate/chloride exchange accounts for about
20% (Aickin and Thomas, 1977a) of intracellular pH recovery.
However, in acidosis resulting from increased skeletal muscle contrac¬
tion the majority of pH recovery arises from lactate efflux of the cell
and Na+/H+ antiport activity (Juel, 1988). Both sodium-dependent and
sodium-independent bicarbonate exchange are inhibited by 4,4 '-di-
isothiocyanostilbene-2,2'-disulphonate (DIDS) (Aickin, 1986; Kahn et
al., 1990)
1.123 Lactate/Monocarboxylate exchanger
Lactate efflux from skeletal muscle is another important mechanism for
controlling pH during contraction (Juel, 1988). There are two mecha¬
nisms responsible for lactate efflux, passive diffusion of lactate down
the lactate concentration gradient and a lactate exchange with an extra¬
cellular hydroxyl ion. This exchange is stimulated by intracellular aci¬
dosis and is inhibited by cinnamate. From in vitro data this exchanger
would appear to be quantitatively as important as the Na+/H+ antiport
in restoring pH during skeletal muscle contraction (Juel, 1988).
1.124 Intrinsic buffering
In addition, to the above mechanisms the cell has intracellular buffers
which prevent changes in pH. These buffers include a variety of
intracellular proteins and in the muscle cell, inorganic phosphate and
phosphocreatine. Collectively buffering from these compounds is given
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the term intrinsic intracellular buffering. Intrinsic buffering varies
depending on the cell type but is of the order of 20-25 mmol of H+
ions/pH unit for myocardium (Wolfe et al., 1988) and about 40-50
mmol H+ ions/pH units for skeletal muscle (Aickin and Thomas, 1977).
1.2 SOME ION TRANSPORT ABNORMALITIES IN
GENETIC HYPERTENSION
There have been numerous reports of altered intracellular cation con¬
centrations and abnormal handling of ions in both patients with essen¬
tial hypertension and spontaneously hypertensive rats. These changes in
ion handling in genetic hypertension are presented in Table 1.1.
Because cell volume and pH regulation requires close control of
sodium, potassium and hydrogen ion concentrations in the cell and as
changes in the handling of these cations are found in hypertension, it
follows that the processes involved in altering ion transport in
hypertension have to be linked in some way to both cell volume and pH
regulation. This will be discussed later in Chapter 10 of this thesis.
1.3 SOME PROBLEMS WITH IN VITRO MEASUREMENT
OF ION TRANSPORT
Over the years numerous hypotheses have been suggested to try and
explain why changes in ion handling of the cell occurs in genetic
hypertension. However, a problem that has faced researchers trying to
produce a unifying hypothesis linking ion transport abnormalities and
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Table 1.1 Reports of abnormal cation transport and intracellular cation




increased Edmondson et al., 1975;
Ambrosioni et al., 1981;
Heagerty et al., 1982; Clegg






unchanged Canessa et al., 1980; Garay
et al., 1980
unchanged Boon et al., 1986; Aalkjaer et
al., 1985
unchanged Nabika et al., 1985; Bukoski,
1990; Pritchard et al., 1989
++
total cell Ca content
increased Erne et al., 1984; Astaire et
al., 1989; Lindner et al., 1987
increased Postnov and Orlov, 1985;
Tobian and Chesley, 1966;
Speiker et al., 1988




increased Simon et al., 1987;Nielson et








Ca++ influx via L-type
Ca++ channels
decreased Edmondson et al., 1975;
Poston et al., 1981; Heagerty
et al., 1982
increased Canessa et al., 1980;
Canessa et al., 1988
increased Livne et al., 1987; Kuriyama
and Aviv, 1987, Izzard and
Heagerty, 1989; for review
see Aalkjaer, 1990
decreased for reviews see Postnov and
Orlov, 1985 and Dominiczak
and Bohr, 1990
increased Rusch and Hermsmeyer,
1988; for reviews see
Postnov and Orlov, 1985 and
Dominiczak and Bohr, 1990
Na+/K+/CI -cotransport variable
activity.
for a review see Chipperfield,
1986
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hypertension is the inconsistency of the reported changes in ion
transport in hypertension. This is particularly so for Na+/K+-ATPase
activity with both increased and decreased activity of this membrane
transport system being reported by different groups (for a review see
Swales, 1982) .These inconsistencies have made it very difficult to
recognize the significance of any given ion transport abnormality.
It has been suggested that these inconsistencies are due to laboratory
variation in in vitro conditions (Swales, 1982; Boon, 1986; Nielsen,
1988). This may not be the only explanation for these apparent
inconsistencies, as will be discussed in Chapter 10, but there are some
problems with in vitro methods of measuring ion flux which I will now
briefly out-line by giving some examples.
Problems with methods of measuring ion flux in vitro can be
considered under three main headings:
1. Cell preparation.
2. Method of measurement.
3. Interpretation of results.
1.31 Cell preparation
Most studies in hypertension have been performed on blood cells be¬
cause these cells are easily obtained. However, the way these cells are
prepared can alter the results obtained. For example, Poston et al.,
(1982) have shown that polymorphonuclear leucocytes isolated by the
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Ficoll/Triosil method have a lower rate constant for sodium efflux than
the same cells prepared by differential sedimentation in dextran.
Differences in temperature of the external media can have an effect on
ion transport (Schwartz et al., 1975). Differences in the media used
may have an unknown effect on ion transport. This is particularly im¬
portant for cells grown in culture where the media contains unknown
growth factors in the form of non-standardized foetal calf serum.
Further problems may also occur if the reason for the ion transport
abnormality is a circulating plasma factor. This may be removed dur¬
ing preparation of the cells.
Furthermore, it has also been shown that cells in culture change there
phenotypic identity (Chamley-Campbell and Campbell, 1981; Owens et
al., 1986; Aalkjaer, 1990) with an alteration of cellular ion transport.
For example, Bukoski (1990) has shown that the intracellular calcium
concentration in the vascular smooth muscle cells of SHRs on primary
culture is normal but increases above normal on subsequent passage
1.32 Method ofmeasurement
Some studies have used unphysiological manipulation of cells. An
example of such a method is that used by Garay and Meyer (1979)
where cells are incubated for 20 hours after inhibiting the sodium
pump with the non-specific inhibitor 2,5-p-chloromercuribenzene
sulphonate (PCMBS). After such a long incubation with a toxic
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compound it is very likely that the cell membrane has been
damaged.This could lead to experimentally -induced differences in
measuremed ion flux across these membranes.
There have been problems in measuring intracellular sodium
concentrations. This stems from the large measurement error that
results from attempting to measure a low intracellular sodium
concentration in the presence of a very high extracellular sodium
concentration. Furthermore, there is recent evidence that much of the
sodium that was considered to be intracellular is attached to the outside
of the cell membrane. This may have led to false reports of elevated
sodium in cells obtained from essential hypertensives (for reviews see
Simon, 1989 and Simon, 1990).This inability to measure true
intracellular sodium concentrations may be responsible for some of the
inconsistent findings altered Na+/K+-pump activity in hypertension.
This is because some methods of measuring Na+/K+ pump activity in
the past have measured sodium efflux from the cell and have calculated
Na+/K+-ATPase activity on the basis of an accurate measurement of
intracellular sodium concentration and sodium efflux from the cell. A
falsely elevated intracellular sodium therefore, would result in an
apparent reduction in Na+/K+-ATPase activity even in the presence of
an increased sodium flux.
Recently there has been considerable interest in measuring Na+/H+ an-
tiporter activity in hypertension. Much work has been done using the
pH sensitive dye bis-carboxyethylcarboxyfluorescein acetoxymethyl
ester (BCECF ester). There is a large error in the measurement of
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intracellular pH using this method (Davies et al.,1991). This variability
could also result in incorrect interpretation. Futhermore, it has been
shown that stimulation of Na+/H+ antiporter activity results in an
alkaline shift in the cell only if the cell is in a non-bicarbonate buffer.
However, this alkaline shift in the cell can be completely removed when
bicarbonate is present in the culture media (for a review see Aalkjaer,
1990).
1.33 Interpretation of results
It is clear from the above discussion, that in vitro results can be influ¬
enced by the experimental method used and may not represent the
changes in ion transport that are present in vivo. Thus, abnormailities
of ion transport found in vitro have to be interpreted on the strength
of the method used and should not automatically be interpreted as
equivalent to the changes in ion transport that occur in vivo.
1.4 THE AIMS OF THIS PROJECT
Problems with in vitro methods of studying cation transport have
prompted the development over the last few years of methods of
studying cation transport in vivo. These methods have been based on
the principle that certain ions which are not found in high concentra¬
tions in the body can be used as markers for endogenous ions, for ex¬
ample rubidium for potassium (Boon et al., 1986) and lithium for
sodium (Brearley et ah, 1988). These techniques have studied ion trans-
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port in blood cells in vivo although measurement of intracellular
cations concentrations were made in vitro.
As an extension of these methods of measuring ion transport in vivo it
was the main aim of this project to determine whether it would be
possible to use nuclear magnetic resonance spectroscopy (NMR) to
study ion transport, non-invasively and entirely in vivo.
However, at the start of this project NMR was not established as a
quantitative tool and previous attempts at quantification had all made
assumptions regarding measurement of tissue volume. Thus, these
methods could not be applied to the measurement of ion concentrations
in vivo where a measurement of sample volume is required.
The first aim of this project therefore, was to develop new NMR tech¬
niques which would overcome the problem of tissue volume measure¬
ment and so measure absolute concentrations of ions in vivo.
It was hoped that if these new techniques could be established, it would
make it possible to the study rubidium (potassium) kinetics in vivo.
Such a study would determine the nature of the change in Na+/K+-
ATPase activity in vivo in genetic hypertension ie. whether Na+/K+-
ATPase activity is reduced or increased in genetic hypertension.
In addition to the study of Na+/K+-ATPase activity,it was hoped that
NMR could be used to make non-invasive measurements of
intracellular pH (Moon and Richards, 1973), in order to study pH con-
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trol and Na+/H+ antiporter activity in hypertension in vivo. The aim
was to determine whether reported in vitro abnormalities of pH control
and Na+/H+ antiporter activity found in association with hypertension
are also present in vivo.
It was hoped that this work would provide a better understanding of the
reasons and mechanisms responsible for abnormalities of ion handling
in genetic hypertension.
SUMMARY
In this chapter I have outlined the basic mechanisms by which cells
control ion movements in order to regulate both volume and intacellu-
lar pH. These mechanisms are relevant to the work that will be pre¬
sented in the following chapters and I believe relevant to the ion
transport abnormalities reported in association with hypertension. I
have briefly oulined the common ion transport abnormalities that are
found in association with genetic forms of hypertension and have
discussed some of the problems with in vitro methods of measuring ion







86Rubidium was obtained from Amersham International pic,
Amersham, Bucks
2.2 DRUGS AND REAGENTS
Rubidium chloride, amiloride, 4,4'-di-isothiocyanostilbene-2,2'-
disulphonate (DIDS) and Isoprenaline were obtained from Sigma
Chemicals, Poole, Dorset. Nifedipine was obtained from Bayer UK
Ltd, Newbury, Berks.
All laboratory chemicals were of analytical grade.
2.3 METHOD FOR MEASURING ABSOLUTE CONCEN¬
TRATIONS OF RUBIDIUM IN VIVO USING 87Rb NMR
SPECTROSCOPY
2.31 Animal preparation
Male Wistar-Kyoto rats (150-300 g) were obtained from Olac Ltd.,
Bicester, UK, and were on a normal rat diet. Each rat then had daily
intraperitoneal injections of rubidium chloride solution, in a dose of 2
mmol/kg/day for a period ranging between 3 and 14 days. The animals
were then anaesthetized with halothane:N20:02 and were placed in a
specially designed radiofrequency coil (Fig. 2.1) in a 1.9 Tesla super¬
conducting magnet. After collection of the NMR spectra from
hindquarter muscle the animals were killed by decapitation and
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aliquots of hindquarter muscle were excised. The muscle was divided
into four 1 g portions. Three portions of muscle were immediately
placed in distilled water to prevent loss of tissue water. One sample
was lyophilized. The total muscle water content was calculated from
the difference between wet and dry weights. The mean tissue water
content of the muscle was 75% of the wet weight. The rubidium con¬
tent of the muscle was measured as described below.
2.32 NMR Spectroscopy
All experiments were performed in a horizontal, wide-bore, 1.9 Tesla
magnet at a frequency of 80.28 MHz for protons and 26.28 MHz for
rubidium. Signals were obtained from rat hindquarter muscle.
2.321 The radiofrequency coil
The earphone coil construction and circuitry are illustrated in Fig. 2.1.
Each coil head had an external diameter of 17 mm and the heads were
positioned 11 mm apart. Having two surface coils opposed to each













Fig. 2.1 (a) Diagram of the radiofrequency coil circuit. For the pur¬
pose of this study the coil was tuned to both and 87Rb, but it can be
tuned to other nuclei , including 31P, 23Na and 7Li. This can be done by
connecting different capacitors at position A. The same coil could be
used to measure all of these nuclei in the same animal, (b) Diagram of
the coil in coronal section, showing the relationship between the sam¬
ple tissue and standards.
When the Bl field is uniform the signal received by the coil from the
sample lying in a uniform part of the B} field, immediately after a 90°
pulse, is proportional to b can be expressed by the following equation:
e.m.f. = toq Bx M0 V (1)
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where e.m.f. is the electromotive force created in the coil by the
sample magnetization, co0 is the angular velocity of the nucleus con¬
cerned, Bj is the the stimulating magnetic field created by unit current
passing through the radiofrequency coil, M0 is the bulk component of
magnetization per unit of sample volume and is proportional to the
number of resonant nuclei in the sample, and V is the volume of sam¬
ple.
2.322 Spectral parameters
For the purpose of this experiment the coil was tuned to both rubidium
and protons, but it could be tuned to other ions, including sodium and
lithium. NMR spectra were collected as 512 data points with a sweep
width of 10 000 Hz for rubidium and as 1024 data points with a sweep
width of ±600 Hz for protons. Pulse widths were obtained at 90° for
rubidium, water, and tetramethylsilane (TMS). The mean pulse width
for rubidium was 15 ps and for protons 22 ps. The water standard,
TMS, experienced a smaller/^ field, due to its position relative to the
centre of the coil, and as a result had a much longer pulse width of 55
(is. In muscle tissue the Tx relaxation time for rubidium was found to
be 500 ps and the T2 relaxation time 350 ps.
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2.33 Predicted NMR visibility
page
The theoretical predicted NMR visibility of rubidium in muscle using a
1.9 Tesla magnet can be expressed by the following equation (Torrey
1949):
tot = 0.4 {exp(-DE/r2*) exp [-(1/7\ + 1 /T2*)tp]} (2)
where Mvis is the detectable magnetization from rubidium nuclei in
muscle tissue; M tot is the total magnetization from rubidium nuclei in
muscle tissue; DE is the dead time of the spectrometer in |is (50 (is); fp
is the pulse width in (is (14-15 (is)
The factor of 0.4 in this equation arises from the fact that the nucleus
of 87rubidium is quadrupolar, of spin -3/2. Compared with other spin -
3/2 nuclei, its NMR relaxation times are short (in aqueous solution TY
= T2 = 2.5 ms (Allis et al 1989). However, in anisotropic biological
environments it exhibits complex relaxation behaviour. Interactions
with both free and membrane-bound proteins and other macro-
molecules cause shortening of the relaxation times. As the line width is
inversely related to the transverse relaxation time (T2 ), the lines are
correspondingly broad. Furthermore, in anisotropic environments spin
-3/2 nuclei are characterized by two T2 times: 60 % of the magnetiza¬
tion relaxes rapidly (T2 fast) and 40 % relaxes more slowly (T2 slow).
These relaxation times depend both on the environment of the nuclei
and the magnetic field strength. These relaxation effects are not spe¬
cific to rubidium and are seen in other spin -3/2 nuclei, such as 23Na
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and 39K (Forsen and Lindman, 1981; Deverell and Richards, 1966). In
a 1.9 Tesla magnet the fast component of transverse relaxation is too
broad to be detected in the spectra. The remaining 40 % of the magne¬
tization has a T2 of about 350 \xs, and this gives the 900-1000 Hz line
width of the above muscle spectrum.
A further reduction in signal intensity arises from relaxation during
the radiofrequency pulse and the spectrometer dead-time, according to
equation 2 (Torrey, 1949). This reduces the expected visibility from
40% to 33%, taking into account the 3% attenuation of the signal from
the calibration solutions (see next section). Thus, although magnetiza¬
tion is detected from all the rubidium nuclei in the anisotropic envi¬
ronment of muscle, the spectrometer detects only 33% of the magneti¬
zation that would be detected in free solution (an isotropic environ¬
ment) from the same number of nuclei.
2.34 NMR standards
2.341 Rubidium
The rubidium standard consisted of 45 |il of a 0.5 M solution of Rbl in
saturated KI solution, sealed in a glass vial. Iodide was used as a shift
reagent, since of the alkali halides it gives the best shift for mbidium
(Fosen and Lindman, 1981). The shift achieved was 55 ppm to a





The water standard consisted of 2 ml of tetramethylsilane (TMS) in a
sealed glass vial, giving a proton shift of 5 ppm to a lower frequency
than water(see Chapter 3; Figs. 3.2b and c).
2.343 Calibration
Both the rubidium and water standards were calibrated with phantoms
of rubidium solutions of different volumes up to 50 ml (ie several
times larger than the volume of a rat's hindquarter). The rubidium
peak area in muscle was compared with the rubidium standard peak
area, and the number of pmol of rubidium in the muscle was obtained
from a calibration graph.
Tissue water was calculated in a similar manner from the peak areas of
the proton spectra of both tissue water and TMS. All areas were mea¬
sured by cutting and weighing plotted spectra.
2.35 Atomic Absorption Spectrophotometry
The 1 g portions of muscle were homogenized in deionized water us¬
ing an Ultraturrax (Model TP18 - 10). The muscle suspension was
spun in a Mistral MSE 4L centrifuge (1400 g at 4°C for 15 min) and
the supernatant was collected. The muscle pellet was resuspended and
this procedure was repeated twice, the supernatant being collected
each time. The pooled supernatant was then spun in a Sorvall RC-5B
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ultracentrifuge (Du Pont instruments) at 40 000 g for 15 min. The re¬
sulting clear supernatant contained 90% of the total tissue rubidium as
assessed from recovery experiments using radioactive 86Rb. This final
supernatant was diluted to an appropriate level to enable measurement
of the final rubidium concentration in triplicate by flame atomic ab¬
sorption spectrophotometry (Varian Atomic Absorption
Spectrophotometer, Model SpectrAA 300/400). The rubidium concen¬
tration of the muscle was expressed as mmol/1 of tissue water
Whole rat blood (5-10 ml) from each animal was spun in a Mistral
MSE 4L centrifuge (1400 g at 4°C for 15 min) to separate the ery¬
throcytes and plasma. Appropriate dilutions were made to enable mea¬
surement of the rubidium concentrations in triplicate by flame atomic
absorption spectrophotometry (Varian Atomic Absorption
Spectrophotometer, Model SpectrAA 300/400). Rubidium concentra¬
tions were expressed as mmol/1 of plasma and mmol/1 of packed ery¬
throcytes.
2.4 METHOD USED TO MEASURE Na+/H+ ANTIPORTER
ACTIVITY IN VIVO
2.41 Animal preparation
Male 13-week old SHRs and age-matched WKY in-bred controls,
ranging in weight from 240 g to 312 g, were obtained from Olac Ltd,
Bicester, UK. Anaesthesia was induced with pentobarbital sodium (30
mg/kg) and was maintained during each experiment with halothane
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(0.5-1.0 % in 1:1 N20:02) delivered through a face-mask. Sciatic
nerve stimulation was used to cause contraction of the plantaris, gas¬
trocnemius, and soleus muscles as a group. The method of preparing
the rats for stimulation of the plantaris-gastrocnemius-soleus muscle
complex has been described previously (Schoubridge et al 1984).
Glycolytic fibres (types Ha and lib) are the main constituent of these
muscles (Armstrong and Phelps 1984). Briefly, the left sciatic nerve
was exposed and a platinum electrode was placed in contact with the
nerve. Brass pins were driven through the knee joint and ankle joint
and the leg was immobilized in a specially-designed Perspex cradle.
The distal tendon of the plantaris-gastrocnemius-soleus complex was
attached to an isometric force transducer and the output was displayed
on a polygraph. The length of muscle which gave maximum isometric
twitch tension in response to a supramaximal sciatic nerve stimulation
was then determined.
The stimulation protocol consisted of pulses of 50 ps pulse-width at
30 V, at a frequency of 10 Hz. The muscle was stimulated for 20 min.
Mean arterial pressure was monitored by an indwelling catheter in the
external carotid artery and was 120 (SD 9.4) mmHg in the WKY rats
(n = 20) and 185 (SD 8.9) mmHg in the SHRs (n = 20).
2.42 NMR spectroscopy
All experiments were performed at a Larmor frequency of 73.8 MHz
for 31P, in a vertical wide-bore 4.3 Tesla magnet. The radiofrequency
coil, which acted as both a transmitter and a receiver, was a Helmholtz
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coil, each head having an external diameter of 15mm. The coil sur¬
rounded the plantaris-gastrocnemius-soleus group of muscles of the rat
leg. Spectra were collected as 2K data points using a sweep width of ±
2000 Hz. Two resting spectra were obtained, one using a nominal tip
angle of 90° and another at a tip angle of 60°. Spectra obtained during
muscle contraction were all obtained using a tip angle of 60°. Spectra
were quantified by computer line-fitting, and the pH was determined
from the chemical shift of Pi from PCr, which was nominally given a
shift of 0 p.p.m. (Moon and Richards, 1973). The acquisition trigger
of the spectrometer was gated such that 32 spectra were collected
every 80 s. The acid measurements thus obtained represented the
average muscle pH during sequential 80 s intervals of muscle
contraction.
2.43 Measurements of metabolite concentrations
Blood and muscle samples were taken from animals both at rest and
after muscle stimulation for 2 min. Blood samples (0.5 ml) were taken
from the indwelling external carotid artery cannula. Muscle samples
were rapidly excised, immediately freeze-clamped in pre-cooled alu¬
minium tongs, and stored in liquid nitrogen. Muscle and blood lactate
concentrations were measured using standard biochemical techniques
(Bergmeyer, 1974). Muscle glycogen was measured after digestion of
the muscle in 1 M KOH and neutralization of the solution in glacial
acetic acid; glycogen was converted to glucose by incubation with
amyloglucosidase (in acetate buffer, pH 4.8) for 2 h at 37 °C and the
glucose was measured enzymatically (Bergmeyer, 1974). Resting ATP,
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phosphocreatine (PCr), and free creatinine concentrations were mea¬
sured using hplc. All metabolite concentrations are reported on a dry
weight basis. The mean wet/dry weight ratio was 4.4 (SD 0.22) for
both SHRs and WKY rats at rest and after stimulation for 2 min. There
was no significant difference in the wet/dry ratio after any treatment.
Absolute concentrations of phosphorus metabolites in the 31P NMR
spectra were calculated assuming complete visibility of ATP and PCr
(Dawson and Wilkie, 1980). The concentration of ATP at rest was
taken to be that of the concentration found using hplc and PCr calcu¬
lated from resting fully relaxed spectra. The concentrations of the
other metabolites at rest were calculated from the resting spectra,
using the ratio of the spectral peak of the metabolite to that of PCr.
Absolute concentrations of metabolites during contraction were then
calculated by comparing the absolute intensity of the respective signal
of each metabolite in a given spectmm during contraction to that of the
resting spectrum, taking into account the saturation effect resulting
from a 60° flip angle.
2.5 Statistical and mathematical methods
Tests of normality were performed on all data (Royston, 1983).
Results were analyzed using unpaired Student's t-tests and one-way
ANOVA applying Dunnett's test and the Fisher's Protected Least
Significant Difference test where appropriate. Areas under curves
(AUCs) were calculated using Simpson's method.
Chapter Three
Measurement of concentrations of rubidium in vivo in rat
87
skeletal muscle by rubidium NMR spectroscopy
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3.1 INTRODUCTION
Rubidium, one of the Group 1 alkali metals, has been shown to substi¬
tute for potassium in a variety of transmembrane transport systems,
and has been used to study the activity of the sodium- and potassium-
activated adenosine triphosphatase (Na+/K+-ATPase, E.C. 3.6.1.37 )
(Bernstein and Israel, 1970; Love and Burch, 1953) and of Na+/K+ co-
transport (Chipperfield, 1986). Like potassium, rubidium is concen¬
trated in the intracellular compartment, the ratio between the intracel¬
lular and extracellular compartments being about 30:1 (Relman, 1956;
Meltzer and Fieve, 1975; Boon et al., 1984). In vitro muscle Na+/K+-
ATPase activity has been measured using mbidium kinetics in several
conditions, including thyroid disease, obesity, old age, and hyperten¬
sion (Clausen, 1986). In hypertension in particular, in vitro studies of
Na+/K+-ATPase activity and Na+/K+ co-transport have resulted in
conflicting results and diverse opinions as to the importance of these
ion transport abnormalities (Swales, 1982). Differing methods of mea¬
suring Na+/K+-ATPase activity in vitro may be the cause of the con¬
fusing results in hypertension.
The particular example of hypertension emphasises the need for non¬
invasive methods of measuring in vivo Na+/K+-ATPase activity. This
has previously been done in man by studying the disposition of mbid¬
ium in plasma and erythrocytes after an oral load of mbidium chloride
(Boon et al., 1984). In order to extend this work to other tissues a
method has now been developed to make in vivo measurement of m-
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bidium concentrations in skeletal muscle using nuclear magnetic reso¬
nance spectroscopy (NMR).
In order to make absolute measurements of a substance by NMR many
problems need to be overcome. These problems are compounded in
vivo (Tofts and Wray, 1988). To date most in vivo NMR studies have
been directed towards the measurement of relative concentrations of
phosphorus metabolites (Radda, 1986), using radiofrequency surface
coils that can be placed on the surface of an animal (Ackerman et al.,
1980). Although the development of the surface coil has made in vivo
NMR much easier, the use of surface coils leads to problems in quan¬
tification, the main problem being that a surface coil does not have a
uniform magnetic ( B\) field. Different parts of the sample therefore
give rise to signals of different intensity, making it very difficult to
obtain absolute concentrations. This problem can be overcome if a
suitable internal standard of the nucleus of interest is present in the
cell. Provided the concentration of this standard is known accurately,
is not involved in cell compartmentation, and does not change with
time, the ratio of this standard to the compound of interest can give an
estimate of tissue concentration. One such standard is naturally-occur¬
ring deuterium oxide (2H20) (McCoy et al., 1988). However, for most
of the commonly studied NMR nuclei no such standard exists. Several
methods have been used to try to overcome the problem of a non-uni¬
form Bx field, but with all of these methods some form of assumption
has been made regarding sample volume (Thurlborn and Ackerman,
1983; Roth et al., 1989; Wray and Tofts, 1986).
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A further complication of in vivo NMR measurement concerns electri¬
cal conduction losses in living tissues (Wray and Tofts, 1986). These
losses attenuate the signal received by the NMR spectrometer in a
sample-dependent manner. Conduction losses are greater in larger
animals and could lead to differences in the signal obtained, indepen¬
dent of the number of nuclei present in the sample.
87Rubidium, a non-radioactive isotope of rubidium, which comprises
30% of natural abundance rubidium, has recently been the subject of
both in vitro and ex vivo NMR studies (Helpem et al., 1987; Allis et
al., 1989). The aim of this work was to develop a method of
measuring absolute concentrations of both tissue rubidium and water,
non-invasively in intact animals, using NMR spectroscopy in a way
that would overcome the problems outlined above. By using this non¬
invasive method of measuring tissue rubidium concentration, it would
then be possible to measure dynamic changes in tissue mbidium in the
same animal, and thus to assess Na+/K+-ATPase activity in vivo.
Measuring changes in tissue mbidium concentration allows assessment
of Na+/K+-ATPase transport activity, since well over 90% of tissue
mbidium is intracellular and 90% of cellular mbidium uptake occurs
as a result of Na+/K+-ATPase activity (Bernstein and Israel, 1970;
Overbeck et al., 1981).
The principle approach has been to use a coil tuned to both 87Rb and
[20], and to measure the total amount of mbidium seen by the coil
and the total amount of water seen by the coil in the same volume of
Chapter 3 page 37






Fig. 3.1a shows a typical muscle spectrum, with a narrow peak arising
from the rubidium standard, shifted 55 p.p.m. to the left, overlapping
a broad peak obtained from muscle rubidium. These peaks are suffi¬
ciently shifted from each other to enable measurement of the areas of
both peaks. Fig. 3.1b shows that the peaks resulting from the protons
of tissue water, tissue fat, and the proton standard Tetramethylsilane
(TMS) are shifted from each other such that overlap does not occur.
Fig. 3.1c shows that when a 90° pulse is applied to the TMS, the water
peak is inverted. There is a small fat peak between the peaks of water





































































































































































































3.32 The effect of increasing conductivity
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In a series of experiments latex phantoms were filled with solutions of
rubidium chloride and sodium chloride. The rubidium concentration
was constant at 20 mmol/1 and sodium chloride was added to give
sodium concentrations of 150 mmol/1 to 4.8 mol/1- This gave solution
conductivities ranging from 1.4 to 192 mS. From Fig. 3.2 it can be
seen that increasing conductivity had no effect on rubidium concentra¬
tion estimation. This result was obtained despite a reduction in the
peak area from both the sample and standard. Increasing conductivity
reduces the efficiency of the coil as both a transmitter and a receiver.
As both the sample and the standard are in a fixed physical relationship
relative both to each other and to the coil, reduced coil efficiency at¬
tenuates the signals from both the sample and the standard to a similar
degree, and the peak area ratio between the two remains constant. If
such ratios are used in the measurement, conductivity, and for similar
reasons variations in tuning and amplifier gain, can have no effect on
rubidium concentration estimations.



























Fig. 3.2. Effect of increasing conductivity on the measurement of ru¬
bidium concentration using latex phantoms filled with the same volume
of 20 mmol/1 rubidium chloride solution.
3.33 Measurement of volume by NMR
Latex phantoms of various volumes, filled with 30 mmol/1 rubidium
chloride solution, were placed in the coil, and NMR spectra were ob¬
tained for both rubidium and water. Fig. 3.3a shows that the wa-
ter/TMS proton ratio increased linearly until the sensitive volume of
the coil (2.7 ml) was exceeded. Above this volume no further increase
in the ratios resulted.
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Fig. 3.3a also shows that the rubidium/rubidium ratio increased lin¬
early until the sensitive volume of the coil (2.7 ml) was exceeded. The
exact overlap of the rubidium/rubidium and the water/TMS proton ra¬
tios shows that the rubidium detected by the coil is contained only
within water which the coil also detects.
Fig. 3.3b and Fig. 3.3c show the respective calibration curves for wa¬
ter and rubidium derived from this volume experiment.
3.34 NMR visibility of rubidium in living tissue
Table 3.1 shows the NMR estimates of tissue rubidium content and
water volume calculated from spectra obtained from the hindquarter
muscle of live rats under anaesthesia. It also shows the mean rubidium
concentration of excised muscle obtained from the same animals, as
estimated by flame atomic absorption spectrophotometry. It can be
seen from these results that the volume of tissue water in these animals
is on the linear part of the volume calibration curve. The tissue rubid¬
ium concentration for each animal as determined by NMR was found
to be 0.31 (SEM 0.04) of that of the rubidium concentration estimated
by flame atomic absorption spectrophotometry. This is close to the
predicted NMR visibility of 0.33 obtained from equation 2.








































(a) Effect of filling the coil with increasing volumes of a 30 mmol/1
rubidium solution on the water/TMS proton ratio (□—□) and on the
sample rubidium/rubidium standard ratio (■ ■). (b) Calibration
curve for increasing amounts of sample water placed in the coil, plot¬
ted against the water/TMS proton ratio. y=0.08 + 1.66x; r=0.990. (c)
Calibration curve for increasing amounts of sample rubidium placed in
the coil, plotted against the rubidium sample/rubidium standard ratio.















































































































































It has been shown here that it is possible to measure rubidium concen¬
trations in rat skeletal muscle in vivo, by measuring the muscle content
of both rubidium and water in the same sample of tissue.
One problem with using NMR to make biological measurements is its
relative insensitivity. Although rubidium is found in trace amounts in
biological tissues, in order to achieve detectable concentrations of ru¬
bidium in tissues using NMR it has to be given exogenously. This has
been done using other NMR visible nuclei, including 7lithium,
13carbon, and 19fluorine (Avison et al., 1986; Burt et al., 1986). In this
study the lower limit of detection of tissue rubidium concentration was
10 mmol/1. Even with larger coils, increasing the sensitivity of detec¬
tion of rubidium, it is unlikely that satisfactory spectra will be
achieved with tissue concentrations of less than 1mmol/1. This may still
not be a problem for the future study of tissue rubidium disposition in
vivo in man and in animals, since rubidium is well tolerated in rat
and man. In this study tissue concentrations of over 30 mmol/1 were
achieved without any adverse effects. In man large doses of rubidium
have been given orally, also without adverse effects (Meltzer and
Fieve, 1975; Fieve et al., 1973). The concentrations reached in the
plasma in such studies in man would result in tissue concentrations
well within the bounds of detectability with NMR, in view of the
known intracellular:extracellular rubidium concentration ratio
(Meltzer and Fieve, 1975).
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The coil design (Fig. 1) ensures a uniform Bx field across the sample
for the in vivo quantification of skeletal muscle rubidium concentra¬
tions by NMR, and this is an essential feature of the method. In con¬
trast, it is not necessary for the standard also to be in a uniform Bl
field. A non-uniform Bx field can result in consistent spectral areas,
provided that a 90° pulse width is used to stimulate the sample and that
differences in conductivity, amplifier gain, and tuning are negligible
from day to day (Tofts and Wray, 1988). However, significant day-to-
day differences do occur, but this problem has been overcome by
maintaining a constant physical relationship between the sample, stan¬
dard, and coil, and by using ratios of signals from the sample and the
standard. The TMS, used as a standard for tissue water, was situated
under the bottom head of the coil, and was therefore in a non-uniform
Bi field. However, the essential point to note about this method is that
the absolute intensity of the signals from both the standard and the
sample can change with alterations in conductivity, amplifier gain, and
tuning, without altering the ability of the method to measure absolute
concentrations. This is so because when the sample and standard are in
a constant physical relationship both to each other and to the coil al¬
terations in coil sensitivity will change the signals obtained from both
the sample and the standard proportionately, and thus the ratio of the
spectral areas will remain constant. This has been clearly shown in this
study in relation to conductivity (Fig. 3.2). Thus, all that is required of
a standard using this method is that it should have a constant physical
relationship to both the coil and the sample, and that its spectral peak
should be of a suitable size compared to the sample peak.
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Using this method it should now be possible to study the rates of
movement of rubidium into and out of skeletal muscle in vivo , thus
enabling direct measurements of the in vivo activity of the transport
systems responsible for these movements, such as the Na+/K+-ATPase
3.5 CONCLUSIONS
In this study nuclear magnetic resonance (NMR) spectroscopy has been
used to measure rubidium concentrations in the skeletal muscle of live
intact rats. Using a 1.9 Tesla superconducting magnet and an ear¬
phone coil tuned to both protons (^H) and rubidium (87Rb), it was
possible to make measurements of both tissue rubidium content and
water content, and from these measurements to obtain rubidium
concentration.
The NMR estimate of rubidium concentration in muscle in vivo was
found to be a constant 31 % (SEM 4 %) of that estimated by flame
atomic absorption spectroscopy in an extract of excised muscle. This is
close to the predicted theoretical NMR visibility of 33 %. The visibil¬
ity was constant for muscle rubidium concentrations ranging between
10 and 34 mmol/1.
Rubidium concentration measurement by this method is unaffected by
variations in sample geometry, sample volume, tissue conductivity,
coil tuning and amplifier gain.
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By using this method to measure changes in tissue rubidium concen¬
tration with time in the same animal, it should now be possible to
assess the in vivo activity of ion transport systems, such as sodium- and
potassium-activated adenosine triphosphatase (Na+/K+-ATPase), by
measuring the rates of change of tissue rubidium concentrations during
the administration of rubidium salts.
This method could also be used to measure the absolute concentration
of any NMR visible nucleus and could be applied to man.
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It has been postulated that in essential hypertension inhibition of
Na+/K+-ATPase activity in vascular smooth muscle cells could result
in increased vascular tone (Blaustein, 1977), although a convincing
mechanism for such an effect is lacking (Swales, 1982). Two types of
evidence have been adduced in support of this hypothesis. Firstly, the
presence in the plasma of increased concentrations of an inhibitor of
the Na+/K+-ATPase (for a review see De Wardener and MacGregor,
1985). Secondly, reports of decreased Na+/K+-ATPase activity, for
example in the leucocytes of patients with essential hypertension
(Edmondson et al., 1975).
However, an endogenous inhibitor has also been reported in associa¬
tion with other diseases, such as chronic renal failure, in which the
blood pressure is not necessarily raised (Cole et al., 1968).
Furthermore, several workers have demonstrated increased rather
than decreased ion transport activity attributable to the Na+/K+-
ATPase in erythrocytes from patients with essential hypertension
(Simon and Engel, 1987), in the leucocytes of their first-degree rela¬
tives (Nielson et al 1988), and in vascular smooth muscle in SHRs
(Pamnani et al., 1980).
In addition to the problems raised by the inconsistency of these re¬
ports, there is the major problem that in-vitro studies may not reflect
the true nature of any change in Na+/K+-ATPase activity which may
have occurred in vivo. This has led to the development of methods of
studying in vivo Na+/K+-ATPase activity in hypertension. In man this
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has previously been done by studying the disposition of potassium and
the potassium substitute rubidium after intravenous and oral adminis¬
tration with the finding that in-vivo potassium and mbidium influxes
are increased in the erythrocytes of patients with essential hyperten¬
sion (Boon et al., 1986). Extending these in vivo studies to a tissue
other than erythrocytes a novel non-invasive method of measuring ab¬
solute intracellular non-radioactive mbidium concentrations in intact
animals by 87Rb nuclear magnetic resonance spectroscopy (87Rb-NMR)
has been developed (see Chapters 2 and 3).
Rubidium has been used for many years as a potassium substitute in
studying potassium fluxes (Bernstein and Israel, 1970; Love and
Burch, 1953) and over 90% of cellular mbidium influx occurs via
Na+/K+-ATPase activity (Bernstein and Israel, 1970; Overbeck et al.,
1981). Thus, the in-vivo rate of accumulation of mbidium in cells can
be used as an index of Na+/K+-ATPase activity. Sequential measure¬
ments of skeletal muscle mbidium concentrations were made, during
the administration of mbidium chloride (RbCl) to SHRs and WKY rat
controls, in order to measure the rate of mbidium uptake into skeletal
muscle in hypertensive and normotensive animals and so to assess
Na+/K+-ATPase activity in these animals.
Skeletal muscle was chosen because it was not possible to study vascu¬
lar smooth muscle in vivo using 87Rb-NMR. SHRs were chosen be¬
cause they have been shown to be a good model of essential hyperten¬
sion (Frolich, 1986), and abnormalities in ion transport, at least in
vitro, are reportedly similar in SHRs and in patients with essential hy¬





15 male 13-week old SHRs, mean (SD) blood pressure (BP) 180 (10)
mmHg, and 15 male age-matched WKY inbred controls, mean BP 120
(10) mmHg, were obtained from Olac Ltd, Bicester, UK. Animals
were maintained on a normal diet. There was no significant difference
in mean body weight between the SHRs and the WKY rats at any time
during the study. Each animal was given a daily dose of 2 mmol/kg of
RbCl intraperitoneally. It has previously been shown that rubidium is
rapidly and completely absorbed in both SHRs and WKY rats within
90 minutes of an intraperitoneal injection (Boon et al 1983). Repeated
87Rb-NMR measurements of muscle rubidium concentrations were
made daily over a period of 3 weeks, each rat contributing three mea¬
surements in all. Rubidium administration was then continued for a
further week, by which time steady-state tissue concentrations had been
reached. RbCl injections were then stopped and further 87Rb-NMR
measurements of muscle rubidium concentrations were made at vari¬
ous intervals, in different animals, up to one week after the last injec¬
tion. At different times after withdrawal, animals were killed and
plasma and intra-erythrocytic rubidium concentrations were measured
by flame atomic absorption spectroscopy. Halothane:N20:02 anaesthe¬
sia was maintained during 87Rb-NMR measurements of muscle rubid¬
ium concentrations. Five rats in each group died towards the end of the




Muscle rubidium concentration measurements were made by measur¬
ing the absolute amounts of both rubidium and water in the muscle as
previously described (see Chapters 2 and 3).
4.23 Atomic Absorption Spectrophotometry
Erythrocytic and plasma rubidium concentrations were measured as
previously described (see Chapter 2).
4.3 RESULTS
Fig. 4.1 shows the increases in muscle rubidium concentrations in both
the SHRs and the WKY rat controls, during daily injections of 2
mmol/kg rubidium chloride (RbCl). There was a higher rate of rise of
rubidium concentrations in the SHR skeletal muscle, but the same
steady-state concentration of 45 mmol/1 was achieved in both SHRs and
WKY rats (95% CI 33-54 for SHRs and 40-54 for WKY rats). Using
the values of ^muscle calculated from the rates of disappearance of ru¬
bidium from skeletal muscle, as shown in Fig.4.2b and as discussed in
detail below, the theoretical curves of appearance of rubidium in
skeletal muscle which should have occurred during the loading phase
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Time (d)
Fig. 4.1 Skeletal muscle rubidium concentrations measured by 87Rb-
NMR. in spontaneously hypertensive rats (■) and Wistar-Kyoto rats
(□) during repeated daily administration of RbCl. The lines which
have been drawn through the data points have been derived from
equation 1 in the text, using values of the elimination rate constant of
rubidium in the muscle derived from the data shown in Fig. 4.2.
Fig. 4.2a shows the falls in skeletal muscle rubidium concentrations in
both SHRs (■) and WKY rats (□) after the withdrawal of RbCl. There
was a greater rate of fall of muscle rubidium in the SHRs compared
with the rate of fall of muscle rubidium in the WKY rats. Both sets of
data fitted single exponentials, and Fig. 4.2b shows a semilog plot of
these
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Muscle Rb concentration
Time (d)
In (Muscle Rb concentration)
In (mmol/l)
Time (d)
Fig. 4.2 (a) Skeletal muscle rubidium concentrations measured by
87Rb-NMR in SHRs (■) and WKY rats (□). (b) Semilog plot of data
shown in (a).
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from which the elimination rate constants (Amuscie) and half-lives
(ti/2 muscle) of rubidium in the muscle have been calculated by least-
squares linearization. The data are shown in Table 4.1. There was a
threefold difference between the values in the SHRs and those in the
WKY rats (P < 0.001).
The single exponential fit to the efflux data suggests that the disposi¬
tion of rubidium can be adequately modelled by a single compartment.
Thus, the elimination rate constant can be used to produce a predicted
curve for the increase in muscle rubidium concentrations during
loading with RbCl from the following equation:
where Css (muscle) is the steady-state concentration of rubidium in mus¬
cle and C(t) is the concentration of rubidium in skeletal muscle at any
time (t) during loading with RbCl. These predicted curves are shown
in Fig. 4.1 overlying the data points. The rises in rubidium concentra¬
tions in skeletal muscle predicted from the elimination rate constants
were very close to the measured values in both groups of rats.
There was a greater rate of fall of both erythrocytic and plasma rubid¬
ium in the SHRs compared with the rate of fall of erythrocytic and
plasma rubidium in the WKY rats. Both sets of data fitted single expo¬
nentials, and Fig. 4.3 shows a semilog plot of the rubidium concentra¬
tions in plasma and erythrocytes in both SHRs and WKY rats plotted
against time in days after the last injection of RbCl. The
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elimination rate constants and half-lives of Rubidium in the plasma
(^plasma and t1/2 plasma) and in erythrocytes (^rbc and t1/2 rbc) were cal¬
culated by least-squares linearization. The data are shown in Table 4.1
There was a threefold difference between the values in the SHRs and
those in the WKY rats for erythrocytes and a twofold difference for
plasma (P < 0.001).
Total clearance of a substance (CL) is given by the equation:
The apparent volume of distribution of a substance (Vz, in litres of
plasma) is given by the equation:
where A,z plasma represents the elimination rate constant from plasma.
The daily dosage of rubidium was the same in both groups of rats but
there was a smaller steady-state plasma rubidium concentration in the
SHRs and so the total clearance of mbidium in the SHRs was greater
(see eqn (2)). This increase in clearance accounted for the increase in
plasma in the SHRs, and there was no difference in the apparent vol¬
ume of distribution of Rubidium in the SHRs (see eqn. (3)) compared
to the WKY rats. The calculated values of Vz and CL are given in
CL — DoSage/Css (plasma) (2)
where CSs (plasma) is the plasma concentration at steady state.
(3)
Table 4.1.
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Fig. 4.3 Erythrocytic (RBC) and plasma rubidium concentrations mea¬
sured by flame atomic absorption spectrophotometry in spontaneously
hypertensive rats (■) and Wistar-Kyoto rats (□) after withdrawal of
RbCl (semilog plot).
4.4 DISCUSSION
In this study whole tissue concentrations of rubidium in rat hindquarter
skeletal muscle were measured non-invasively in vivo during repeated
administration of RbCl and after its withdrawal. It can be calculated
that about 98% of the total concentration of rubidium is intracellular.
This is based on the assumption that interstitial fluid has the same ru¬
bidium concentration as plasma. The steady-state concentrations of
rubidium in whole tissue, plasma, and erythrocytes were 45 mmol/l,
1 mmol/l, and 20 mmol/l respectively (Figs. 4.2 and 4.3). Thus, the
contribution of erythrocytic rubidium and extracellular (plasma) ru-
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bidium to the total tissue rubidium signal is of the order of two per
cent. In contrast, both intracellular and extracellular water contribute
to the NMR proton signal, and so 87Rb-NMR measurements of tissue
rubidium concentrations underestimate intracellular rubidium concen¬
trations.
There was a higher rate of accumulation of rubidium concentrations in
the skeletal muscle of the SHRs compared with the skeletal muscle of
the WKY rats during loading with the same dose of RbCl, in conjunc¬
tion with a marked increase in the rate of efflux of rubidium from
SHR muscle after withdrawal. Since at steady-state muscle rubidium
concentrations were the same in SHRs and WKY rats, these findings
imply that there was an increase in the rate of mbidium influx into
SHR skeletal muscle and that this increase was equal in degree to the
increase in the rate of rubidium efflux from the muscle. This interpre¬
tation is supported by the finding that the observed time-course of in¬
tracellular mbidium accumulation was closely predicted from the
elimination rate constant calculated from the data obtained after the
withdrawal of RbCl (Fig. 4.2).
A similar difference in the rate of efflux of mbidium from the ery¬
throcytes of the SHRs, in conjunction with the same steady-state intra-
erythrocytic concentrations in both SHRs and WKY rats, also implies a
similar increase in the rate of mbidium influx from erythrocytes in
the SHRs.
Over 90% of cellular mbidium uptake occurs via Na+/K+-ATPase
transport activity in both rat and man (Bernstein and Israel, 1970;
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Overbeck et al., 1981). In the rat this has been shown in brain and
erythrocytes, and it is likely that it also applies in skeletal muscle.
Thus, the degree of increase in the rate of in vivo rubidium influx into
both skeletal muscle and erythrocytes shown here implies that Na+/K+-
ATPase transport activity in SHRs is markedly increased in vivo.
The threefold increase in the rate of mbidium efflux shown here in
vivo in both skeletal muscle and erythrocytes is comparable with the
threefold increase in the rate of efflux of K+ which has been shown in
vitro in erythrocytes obtained from SHRs and from patients with
essential hypertension (Orlov et al., 1989).
This increase in the rate of efflux of K+ from erythrocytes obtained
from both essential hypertensive patients and SHRs has been shown to
be due to an increased rate of efflux via calcium-activated K+ channels
(Orlov et al., 1989). Since calcium-activated K+ channels are present
in skeletal muscle (Golowasch et al., 1986), it is possible that the in¬
creased rubidium efflux from skeletal muscle in SHRs found in this
study could also result from increased opening of calcium-activated K+
channels. However, the mbidium efflux could also be linked to a regu¬
latory volume decrease, in response to a cell volume increase, caused
by an increase in the activity of the Na+/H+ antiporter in skeletal
muscle, as I shall now argue.
As will be shown (see Chapter 5) there is evidence that Na+/H+ an¬
tiporter activity is increased in vivo in the skeletal muscle of SHRs.
Thus, this form of hypertension in the rat is associated with increased
Na+/H+ antiporter activity, increased Na+/K+-ATPase activity, and an
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increased rate of rubidium efflux (and by implication an increased rate
of K+ efflux).
The major mechanisms whereby cells increase their volume are via in¬
creased Na+/H+ antiporter activity and increased HCO3VCI" exchange
(for review Hoffman and Simonsen, 1989). Thus, an increase in
Na+/H+ antiporter activity, would result in a tendency for the cell to
increase in volume, and this would in turn activate the main mecha¬
nism for reducing cell volume, namely K+ and CI" effluxes. This may
or may not be calcium dependent (Hoffman and Simonsen, 1989).
Increased Na+/H+ antiporter activity in conjunction with increased K+
and CI" effluxes would increase intracellular Na+ and decrease intracel¬
lular K+ concentrations, which would in turn increase Na+/K+-ATPase
activity (Schwartz et al., 1975).
In addition to the differences between SHRs and WKY rats, it will also
be noted that there are differences within each group of animals be¬
tween the values of tj# plasma on the one hand and t1/2 muscle on the
other, the former being longer than the latter (Table 4.1). This implies
that the fall in muscle rubidium in both SHRs and WKY rats is deter¬
mined by a factor other than renal elimination of rubidium, and is
evidence that rubidium is redistributed to other tissues of the body
from muscle after withdrawal of RbCl. Furthermore, there is in vitro
evidence that renal Na+/K+-ATPase activity is not altered in SHRs
(Garg et al., 1985). Although the SHRs had a greater clearance of ru¬
bidium than WKY rats (Table 4.1), the faster rate of fall of muscle
rubidium concentrations in the SHRs cannot entirely be explained by
increased rubidium clearance and is evidence for a faster rate of redis-
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tribution of rubidium from muscle after RbCl is withdrawn in SHRs.
This faster rate of rubidium redistribution may also be evidence for
increased Na+/K+-ATPase activity in tissues other than skeletal muscle
in the SHRs.
This redistribution of rubidium from skeletal muscle to other tissues
suggests that skeletal muscle acts as a store for K+, so that during ei¬
ther excessive K+ loss or reduced K+ intake, plasma K+ concentrations
are maintained at the expense of muscle K+. This would explain the
findings of others, that during K+ depletion plasma K+ concentrations
are maintained despite marked falls in skeletal muscle K+ (Heppel,
1939; Nprgaard et al., 1981). The fall in K+ concentration during K+
depletion in skeletal muscle has also been shown to occur in vascular
smooth muscle (Aalkjasr et al., 1985) and so similar mechanisms may
control K+ concentrations in these two tissues. However, in contrast,
myocardial K+ concentration falls only slightly and brain and liver K+
concentrations are maintained during K+ depletion (Kjeldsen et al.,
1984), which suggests that the mechanisms responsible for controlling
K+ concentrations in these tissues are different.
4.5 CONCLUSIONS
This study has shown that the rates of influx and efflux of rubidium
are equally increased in skeletal muscle in SHRs in vivo and that the
rate of rubidium efflux is increased in their erythrocytes. The in¬
creases in the rates of rubidium influx and efflux were balanced, so
that there was no difference in the steady-state concentrations of
rubidium in either skeletal muscle or erythrocytes. These findings
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suggest that in the skeletal muscle and erythrocytes of SHRs there is
increased Na+/K+-ATPase activity and an increased rate of K+ efflux.
It has also shown that SHRs had a faster redistribution of skeletal
muscle rubidium than WKYrats, and this could be explained by
increased Na+/K+-ATPase activity in tissues other than skeletal muscle
and erythrocytes in the SHR.
These findings of increased in vivo Na+/K+-ATPase activity are
against the hypothesis that inhibition of Na+/K+-ATPase is responsible
for increasing vascular tone in hypertension. It is much more likely
that changes in Na+/K+-ATPase activity found in association with hy¬
pertension are due to altered intracellular Na+ and K+ concentrations,
which could in turn result from increased Na+/H+ antiporter activity
and increased K+ and CP effluxes. This will be discussed later (see
Chapter 9).
This work also shows the importance of skeletal muscle in K+ ho-
moeostasis and in conjunction with other published work it suggests
that the mechanisms controlling potassium concentrations in skeletal
muscle are different from mechanisms in other tissues, such as the
brain and cardiac muscle.
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Increased activity of the Na+/H+ antiporter has been found in vitro in
cells obtained both from patients with essential hypertension (Livne et
al., 1987) and from vascular smooth muscle cells of the spontaneously
hypertensive rat (Kuriyama and Aviv, 1987). In addition, it has been
shown that short-term exposure to vasoconstrictors such as angiotensin
II and endothelin increases the activity of the Na+/H+ antiporter in vas¬
cular smooth muscle (Canessa et al., 1988; Richards et al., 1989).
However, it is not known whether increased Na+/H+ antiporter activity
causes, or results from, increased vascular smooth muscle contraction.
The Na+/H+ antiporter is one of the most important mechanisms for
controlling intracellular pH, and it does this by exchanging extracellu¬
lar Na+ ions for intracellular H+ ions. The properties of the Na+/H+
antiporter have been described in detail in several recent reviews
(Aronson and Boron, 1986; Grinstein and Rothstein, 1986; Madshus,
1988; Hoffman and Simonsen, 1989; Seifter and Aronson, 1986).
Antiporter activity is mainly controlled by changes in intracellular H+
ion concentrations, cytoplasmic H+ ions acting as allosteric activators
of Na+/H+ exchange (Aronson et al., 1982), and the Na+/H+ exchange
is driven by the combined transmembrane gradients of Na+ ions and
H+ ions, with a stoichiometry of 1:1. In skeletal muscle the Km of the
exchanger is 6.9 x 10-8 M, equivalent to a pH of 7.16 (Vigne et al.,
1985). External H+ ions can also act as non-competitive inhibitors of
external Na+ ions, and can alter antiporter activity within the physio¬
logical range of external pH (Vigne et al.,1982). A low intracellular
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Na+ concentration also alters antiporter activity, by causing a shift in
the Km of the antiporter towards a more alkaline pH (Grinstein et al.,
1984).
A possible link between increased Na+/H+ antiporter activity and in¬
creased vascular smooth muscle tone in essential hypertension is via
interactions with the calcium-activated proteins important for muscle
contraction, although these interactions are complex. The actions of
several such proteins, including calmodulin, are reduced by increased
intracellular acid (Roos and Boron, 1981; Fabiato and Fabiato, 1978;
Busa and Nuccitelli, 1984). For example, in vascular smooth muscle
calmodulin, when complexed with calcium, regulates the phosphoryla¬
tion ofmyosin light-chain kinase, which results in smooth muscle con¬
traction (Carafoli, 1987). On the other hand, Ca++-calmodulin also
activates Ca++-ATPase, which controls resting cytosolic Ca++ and is the
main mechanism responsible for vascular smooth muscle relaxation
(Carafoli, 1988). Any change in cytosolic acid caused by altered
Na+/H+ antiporter activity will affect both of these actions of
calmodulin and the net effect on the force of contraction will depend
on the balance achieved between these two mechanisms. It is not clear
to what extent these two different mechanisms would be altered by
changes in Na+/H+ antiporter activity. However, several workers have
shown that increased antiporter activity leads to blunting of agonist-
mediated Ca++ transients and a reduction in the amplitude of Ca++-de-
pendent vascular smooth muscle contraction (Berk et al., 1987b;
Galizzi et al., 1987). Thus, it has been proposed that increased Na+/H+
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antiporter activity and reduced cytosolic acid may by these actions re¬
duce vascular tone rather than increase it (Aviv, 1988).
Previous studies of Na+/H+ antiporter activity in hypertension have all
been made in vitro (Livne et al., 1987; Kuriyama and Aviv, 1987) or
ex vivo (Izzard and Heagerty, 1989). In vitro experiments on skeletal
muscle have shown that the Na+/H+ antiporter is responsible for about
80% of the pH recovery after acidification (Aickin and Thomas,
1977a). With this knowledge it can be predicted that if there was any
significant alteration in Na+/H+ antiporter activity in skeletal muscle in
vivo, it would be detected by an altered cytosolic acid response during
31
contraction. In this study phosphorus nuclear magnetic resonance
31
spectroscopy ( P NMR) was used to make in vivo measurements of
the changes in cytosolic acid concentrations in skeletal muscle during
isometric contraction, in both spontaneously hypertensive rats (SHRs)
and normotensive Wistar-Kyoto (WKY) rats. Skeletal muscle was
studied because of the difficulty of measuring in vivo pH changes in
31vascular smooth muscle using P NMR. Furthermore, the change in
muscle tension was measured simultaneously in order to examine the
relationship between muscle tension development and changes in cy¬
tosolic acid. The cytosolic acid response during contraction was also
studied with and without amiloride, an inhibitor of the Na+/H+ an¬





5.3 RESULTS AND PARTICULAR DISCUSSION
5.31 Altered acid response during isometric muscle con¬
traction produced by sciatic nerve stimulation
During isometric muscle contraction the rate of rise of cytosolic acid
and the maximum cytosolic acid concentration achieved were signifi¬
cantly lower in the SHRs than in the WKY rats. These results are
shown in Fig. 5.1a, where they are compared with the results of the
same experiment carried out in the presence of amiloride (Fig. 5.1b),
as discussed below. The AUC between 0 and 600 s was significantly
lower in the SHRs than in the WKY rats (P=0.006) in the absence of
amiloride. In both SHRs and WKY rats the acid concentration rose to a
maximum after 200 s and then fell to slightly above resting values,
remaining at this value despite continued stimulation. The rate of fall
of acid was the same for both SHRs and WKY rats.
This difference in the change in cytosolic acid concentration during
stimulation could result from one or more of the following mecha¬
nisms:
i) an altered rate of acid production;
ii) different cytosolic buffering of acid;
iii) an altered rate of acid efflux.
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Fig. 5.1 Changes in muscle cytosolic acid during 10 Hz isometric con¬
traction produced by sciatic nerve stimulation in SHRs (■) and WKY
rats (□) (a) before (n=6) and (b) after (n=5) the intra-arterial adminis¬
tration of 0.4 mmol/kg amiloride. Bars show SEM.
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The possible roles of these different mechanisms were investigated,
with the following results.
5.311 Acid Production
There were no significant differences between resting concentrations
of muscle lactate, blood lactate, or glycogen in the two groups of rats.
This was also the case after 2 min of muscle stimulation (Table 5.1).
These results imply similar rates of glycogenolysis and lactic acid pro¬
duction during muscle contraction in SHRs and WKY rats.
5.312 Cell Buffering
31
Typical P NMR muscle spectra obtained at rest and during stimula¬
tion are shown for both SHRs and WKY rats in Figs. 5.2 a and b. They
may be compared with the results of the same experiment carried out
in the presence of amiloride (Figs. 5.2c and 2d), as discussed below. At
rest the inorganic phosphate (Pj) peak was very small and the phos-
phocreatine (PCr) peak large. During muscle stimulation in both SHRs
and WKY rats the PCr peak reached a minimum after 120 s and then
started to increase in size again. There was a significant difference in
the resting concentrations of PCr in SHR and WKY rat muscle
(P < 0.001). The reason for this is uncertain. The changes in muscle
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Fig. 5.3 Changes in muscle phosphocreatine (PCr) concentra-
tion(jimol/g dry weight) during sciatic nerve stimulation in sponta¬
neously hypertensive rats (■) and Wistar-Kyoto (□) rats. Bars show
s.e.m.; n=6).
Although ATP hydrolysis produces H+ ions, PCr breakdown occurs at
a faster rate than ATP hydrolysis, and as this process uses up H+ ions
the net effect is a reduction in the overall rise in intracellular acid
during contraction. Therefore, in skeletal muscle PCr acts as one of
the most important intracellular buffers in skeletal muscle (Wolfe et
al., 1988). From Fig. 5.3 it can be seen that there was a similar fall in
PCr during muscle contraction in the SHRs and the WKY rats. The
rate of ATP utilization was also the same in the two groups of rats: the
similarity in lactate production in the SHRs and WKY rats implies that
ATP production was the same, since these muscles are glycolytic
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(Armstrong and Phelps, 1984); the similarity in the rate of fall in
skeletal muscle ATP concentrations therefore, during contraction in
the SHRs and the WKY rats (data not shown), then implies that the rate
of ATP utilization was also the same. In addition, the changes in the
concentrations in Pj were also the same between SHRs and WKY rats
which suggests that differences in buffering from Pj were not different
in the two groups.
Thus, these results imply that a difference in cytosolic buffering from
changes in PCr and P, would not explain the difference in acid rise
between SHRs and WKY rats during muscle contraction.
An alternative mechanism for the buffering of cytosolic contents is via
bicarbonate influx. However, the effects of amiloride on the acid re¬
sponses in SHR and WKY rat muscle, described below, suggest that the
difference in acid response in contracting skeletal muscle between
SHRs and WKY rats is not due to this mechanism.
The possible involvement of other cellular buffers is unlikely, since
together PCr, Pj and bicarbonate account for almost all sarcoplasmic
buffering (Wolfe et al., 1988).
5.313 Acid Efflux
The blood lactate concentrations at rest and after stimulation for 2 min
in both groups of rats are shown in Table 5.1. Acid efflux from
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skeletal muscle cells can occur either from efflux of lactate or by H+
ion efflux via Na+/H+ exchange. Lactate efflux from muscle has been
shown to occur via two mechanisms, passively down its concentration
gradient, and also in exchange for extracellular hydroxyl ions via a
lactate monocarboxylate exchanger (Juel, 1988). If one assumes that
the uptake of lactate by the liver is the same in the WKY rats and the
SHRs, the lack of difference between the blood lactate concentrations
in the SHRs and WKY rats both at rest and during contraction implies
that the rates of lactate efflux from the skeletal muscle are the same in
both SHRs and WKY rats.
5.31 The effects of amiloride
The above results suggest that the reduction in acid response in the
SHRs is due either to an increase in the activity of the Na+/H+ an-
tiporter, or to an increase in bicarbonate influx. Bicarbonate influx has
been shown to account for about 20% of the acid recovery after mus¬
cle acidification with ammonium chloride (Aickin and Thomas,
1977a), but in a recent study the recovery of cytosolic pH after muscle
contraction was shown to be entirely due to the Na+/H+ antiporter ac¬
tivity and lactate efflux (Juel, 1988). Nevertheless, in order to investi¬
gate the possibility that increased bicarbonate influx, rather than in¬
creased Na+/H+ antiporter activity, was the cause of the difference in
acid response between SHRs and WKY rats, the effects of the Na+/H+
antiporter inhibitor amiloride was studied on the acid responses in
SHRs and WKY rats, and the results are shown in Fig. 5.1b, for
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comparison with the similar experiment carried out in the absence of
amiloride.
In both SHRs and WKY rats amiloride caused a significant shift in the
pH at rest to a mean of 6.93 SD (0.07) for WKY rats and 6.93 (SD
0.04) for SHRs, compared with a mean of 7.05, SD (0.02) for SHRs
and 7.04, SD(0.03) for WKY rats without amiloride (P < 0.001).
Amiloride also removed the difference in the acid response during
contraction between the WKY rats and the SHRs. The pattern of acid
response was also altered, in that in both groups of animals the acid
concentrations failed to return to resting values and remained above
0.4 p.M for the duration of the contraction. As discussed below, this
result implies that the difference in acid response during sciatic nerve
stimulation is due to increased activity of the Na+/H+ antiporter in the
SHRs.
Despite a dose of amiloride sufficient to inhibit the Na+/H+ antiporter
completely, the maximum cytosolic acid concentration reached in the
presence of amiloride in both groups of rats was less than the maxi¬
mum acid concentration reached in the WKY rats without amiloride.
31
Figs. 5.2c and 5.2d show the changes in the P NMR spectra obtained
during muscle contraction in SHR and WKY rats given 0.4 mmol/kg
amiloride, for comparison with the spectra obtained in the absence of
amiloride (Figs. 5.2a and 5.2b). The sugar phosphate peak increased
markedly during the first 200 s, as in the animals not pretreated with
amiloride. However, in the presence of amiloride the sugar phosphate
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peak did not decrease in size after 200 s of sciatic nerve stimulation,
and persisted throughout the period of contraction. This persistent in¬
crease in sugar phosphate most probably reflects continued inhibition
of phosphofmctokinase activity by continuously elevated cytosolic acid
(Trivedi and Danforth, 1966).
31
After amiloride, the resting muscle P NMR spectra in the WKY rats
showed a greater Pj and a smaller PCr peak, the sugar phosphate peak
remaining unchanged. In contrast, the resting spectra in the SHRs
given amiloride showed no change in the Pj or PCr peaks, but a
marked increase in the sugar phosphate peak. These changes in the
resting spectra occurred in association with a significant reduction in
resting muscle glycogen concentration and an increase in resting
muscle lactate concentration in the SHRs (Table 5.2). This implies in¬
creased resting glycogenolysis and glycolysis in SHRs in the presence
of amiloride.
5.33 Changes in muscle tension development
From Fig. 5.4 it can be seen that in association with the different re¬
sponse of cytosolic acid during muscle contraction, there was also a
marked difference in the pattern of twitch tension response between
the SHRs and the WKY rats. The initial muscle tension produced from
a single twitch was the same for the SHRs and the WKY rats, and
ranged between 3 and 4 Newtons (N). However, during isometric
contraction the WKY rats developed a mean maximum muscle tension
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developed by SHRs was only 5.0 N (SD 0.5) (P < 0.001), despite a
smaller rise in cytosolic acid. There was also a greater relaxation of
muscle between twitches in the SHRs. In both SHRs and WKY rats the
muscle tension increased to a maximum after 60 s and then fell to a
steady level, which was less than 50% of the original twitch tension
and was unaffected by the return of cytosolic acid to baseline
concentrations. This reduction in muscle tension with continued low-
frequency stimulation has been described before, and is a characteristic
feature of glycolytic fibres (Edwards et al., 1977).
After amiloride, the maximum muscle tension developed during iso¬
metric contraction was 7 N (SD 0.5) in both SHRs and WKY rats, and
the relaxation in muscle contraction between twitches also the same,
although markedly reduced, as was the steady-state twitch tension.
The difference in the maximum muscle tension achieved between SHRs
and WKY rats implies less accumulation of calcium during contraction
in the skeletal muscle of the SHRs as compared with the WKY rats,
leading to decreased summation of contraction in the SHRs (Luttgau
and Stephenson, 1986). This could be due to either reduced release of
calcium within the cell in the SHRs or to increased efflux of calcium




5.41 Possible mechanisms of the increase in Na+/H+ anti-
porter activity in SHRs
The finding of increased in vivo activity of the Na+/H+ antiporter
in skeletal muscle could be due either to increased numbers of ac¬
tive antiporters in the muscle cell membrane, i.e. an increase in the
maximum velocity of IT1" ion elimination from the cell (Vmax), or
to an increase in the affinity of the antiporter for internal H+ ions,
ie a reduction in the apparent Km of the antiporter, with increased
H+ ion transport at lower H+ ion concentrations. Form the data ob¬
tained in this study it is more likely that the altered antiporter ac¬
tivity in the skeletal muscle of SHRs is due to increased numbers of
antiporters, for the following reasons. The amiloride experiment
shows that the Na+/H+ antiporter is almost entirely responsible for
the pH recovery during skeletal muscle contraction in vivo, because
amiloride inhibited the recovery of acidosis during contraction. At
the peak acid concentration during contraction, corresponding to a
pH of about 6.0, the antiporter would be working at or near to its
Vmax, assuming the Km of the antiporter in skeletal muscle to be
7.16 (Vigne, 1982). As lactate production and efflux were also the
same in the two groups of rats, the rate of fall of cytosolic acid
after the peak acid concentration was achieved is a good approxi¬
mation of the rate of H+ ion efflux via the Na+/H+ antiporter. Since
the rate of fall of cytosolic acid from maximum was similar in the
SHRs and WKY rats, the Vmax of the Na+/H+antiporter in skeletal
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muscle is likely to be the same in the two groups of animals. Thus,
the differences in the rate of rise of cytosolic acid and the peak cy-
tosolic acid concentrations achieved are more likely to be due to in¬
creased antiporter activity in the SHRs, resulting from a shift in the
Km of the antiporter in skeletal muscle towards a more alkaline pH.
A shift in the Km of the Na+/H+ antiporter should lead to an alka¬
line shift in the resting pH. However, although the resting pHs in
the SHRs were slightly more alkaline, this difference did not reach
significance. The reason for this may be that increased Na+/H+ an¬
tiporter activity at rest in vivo would increase the concentration of
intracellular HCO3" leading to increased HCO3 /Cl~ exchange
(Aickin and Thomas, 1977a) and increased HCO3" efflux. This
would mask the change in pH resulting from altered Na+/H+ an¬
tiporter activity in the SHRs.
Numerous activators of the Na+/H+ antiporter have been identified,
including serum growth factors, insulin, phorbol esters, diacyl
glycerol and vasopressin (Grinstein and Rothstein, 1986). The an¬
tiporter can also be stimulated by osmotic cell shrinkage (Hoffmann
and Simonsen, 1989), and this has been shown to occur in skeletal
muscle (Abercrombie and Roos, 1983). Calcium, by activating
calmodulin-dependent protein kinases, also appears to be necessary
for the full action of activators of the antiporter in some cells , in¬
cluding vascular smooth muscle (Seifter and Aronson, 1986;
Mitsuhashi and Eves, 1988). Increased concentrations of cyclic
AMP have been shown to increase Na+/H+ antiporter activity in
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trout red blood cells, mediating the action of B-adrenoceptor ago¬
nists (Borgese et al., 1987), although in kidney brush border cyclic
AMP inhibits the Na+/H+ antiporter (Grinstein and Rothstein,
1986).
It has been shown that differentiated skeletal myocytes in culture do
not increase the Vmax or reduce the Km of their Na+/H+ antiporter
when incubated with either growth factors or phorbol esters,
although changes in the Vmax and Km in response to these agents
do occur in undifferentiated myoblasts (Vigne et al., 1985). The
cause of the increased Na+/H+ antiporter activity in vivo in the
SHRs is therefore not likely to be due to the action of either growth
factors or to changes in protein kinase C, which is activated by
phorbol esters.
Which, if any, of the other above mechanisms is responsible for the
finding of increased in vivo Na+/H+ antiporter in the skeletal mus¬
cle of SHRs is not clear. However, there are three major mecha¬
nisms which should be considered.
5.411 Cell volume regulation
It is possible that the increased antiporter activity in the skeletal
muscle of the SHRs could have occurred as part of a cell volume
regulatory mechanism. It is known that cells can increase their
Na+/H+ antiporter activity in response to shrinkage (Hoffman and
Simonsen, 1989). Such a stimulus could result from increased
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potassium efflux, which is the main mechanism of cell volume re¬
duction (Hoffman and Simonsen, 1989). Work was presented in
chapter 4 that there is a marked increase in the rate of efflux in
vivo of rubidium from the skeletal muscle of SHRs given rubidium
chloride to steady state. This suggests that there may be increased
efflux in vivo of potassium from skeletal muscle in SHRs, and this
has also been shown in rat erythrocytes (Orlov et al., 1989). Thus,
increased antiporter activity in skeletal muscle cells in SHRs may
result from a volume regulatory response.
5.412 Changes in cytosolic calcium concentrations
Increased Na+/H+ antiporter activity in vascular smooth muscle and
cardiac muscle has also been shown to be strongly coupled to in¬
creased cytosolic calcium (Seifter and Aronson, 1986; Hatori et al.,
1987). Although calcium does not directly stimulate the Na+/H+ an¬
tiporter in vascular smooth muscle it appears to be necessary for
the action of both protein kinase C-dependent and protein kinase C-
independent activation of the antiport (Mitsuhashi and Eves, 1988).
The cytosolic Ca++ concentration has been shown to be increased in
several tissues in the SHR, including vascular smooth muscle
(Speiker et al., 1988; Furspan and Bohr, 1986; Bruschi et al.,
1985). If the resting concentration of calcium is increased in skele¬
tal muscle cells in SHRs, this could be another explanation of the in¬
creased Na+/H+ antiporter activity reported here.
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5.413 Altered sympathetic nervous system activity
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It has been shown by several workers that established hypertension in
the SHR is associated with increased sympathetic nervous system activ¬
ity (Falkow et al., 1972; Lee et al., 1986), which would result in
stimulation of B-adrenoceptors in skeletal muscle. This would in turn
increase concentrations of cyclic AMP, which could then increase
skeletal muscle Na+/H+ antiporter activity in the SHR. This could
occur either through a direct activation of the antiporter by cyclic
AMP, as has been proposed for trout erythrocytes (Borgese et al.,
1987), or via increased calcium influx through the action of cyclic
AMP at potential-operated calcium channels in the skeletal muscle
sarcolemma (Carafoli, 1987). A catecholamine-mediated increase in
Na+/H+ antiporter activity would also be consistent with the finding in
both skeletal muscle and cardiac muscle that catecholamine release
accompanying extracellular acidosis attenuates the change in cytosolic
pH in these tissues (Clancy et al., 1976).
5.42 The effects of amiloride on skeletal muscle metabol¬
ism in the SHR
From this work there is evidence of increased glycogen breakdown
and increased glycolysis in the skeletal muscle of SHRs after a dose of
amiloride. Glycogen breakdown is stimulated by increases in cyclic
AMP, Ca++, and Pj (Rennie and Edwards, 1981). As can be seen from
the resting spectra in Figs. 5.2c and 5.2d, the inorganic phosphate peak
was smaller in the SHRs compared with the WKY rats, making
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increased availability of P; an unlikely cause of the increased
glycogenolysis in SHRs under these conditions. It has also been shown
that amiloride in high concentrations produces a dose-dependent
reversible inhibition of the catalytic unit of adenylate cyclase, thus
reducing cellular concentrations of cyclic AMP (Mahe et al., 1985).
Some inhibition of adenylate cyclase would be expected at the dose of
amiloride used in this study, which makes increased concentrations of
cAMP an unlikely cause of the increased glycogenolysis. This leaves
the interesting possibility that the increase in glycogenolysis at rest in
the SHRs in the presence of amiloride occurred as a result of increased
cytosolic calcium, and provides a link between altered calcium
metabolism and increased Na+/H+ antiporter activity.
5.43 The relationship between Na+/H+ antiporter activity
and muscle relaxation in both skeletal and vascular smooth
muscle following contraction
In a recent study comparing the contractile responses of subcutaneous
arteries obtained from patients with essential hypertension and from
normotensive controls, blood vessels obtained from patients with
essential hypertension showed a marked increase in the speed of re¬
laxation following contraction (Aalkjasr et al., 1989). This result is
consistent with the similar finding in skeletal muscle in this study and
suggests that increased relaxation following contraction is a feature of
both vascular smooth muscle and skeletal muscle in hypertension.
Furthermore, it has been shown that Na+/H+ antiporter activity in vas¬
cular smooth muscle in vitro is increased in SHRs (Kuriyama and
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Aviv, 1987) and this is consistent with the finding in skeletal muscle in
vivo in this study. Thus, increased Na+/H+ antiporter activity in both
skeletal muscle in vivo and vascular smooth muscle in vitro is found in
association with increased muscle relaxation.
5.44 Possible mechanism for the differences in muscle con¬
tractility between SHRs and WKY rats
During contraction of skeletal muscle there are large increases in cy-
tosolic calcium, and the two main mechanisms responsible for the bulk
removal of calcium from the cytosol are the sarcolemmal Na+/Ca++
exchanger and Ca++-ATPase activity in the sarcoplasmic reticulum
(Carafoli, 1987; Carafoli, 1988). Of the two mechanisms of bulk cal¬
cium removal, increased Ca++-ATPase activity is most likely to be re¬
sponsible for the increase in relaxation of skeletal muscle contraction
between twitches seen in the SHRs in this study. This is because Ca++-
ATPase activity is the main mechanism by which calcium efflux occurs
during muscle contraction (Carafoli, 1988) and increased Na+/H+ an¬
tiporter activity would, by reducing the sodium gradient, be expected
to reduce Na+/Ca++ exchange. An increase in Ca++-ATPase activity
could result from altered calmodulin activity secondary to increased
Na+/H+ antiporter activity. However, further work in this area is nec¬
essary to determine whether increased Ca++-ATPase activity is re¬
sponsible for the increased skeletal and vascular smooth muscle re¬
laxation, and whether these changes result from increased Na+/H+ an¬
tiporter activity or another mechanism.
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The reduction in maximal muscle tension developed in the SHRs can
also be explained by increased Ca++-ATPase activity. Although this is
also compatible with increased relaxation of the muscle, as discussed
above, it does not necessarily imply that there would be less tension in
SHRs muscle at lower levels of stimulation. Since it is known that the
vascular smooth muscle of SHRs has an increased rate of relaxation
and a normal response to agonists in vitro (Aalkjaer et al., 1989), this
implies that hypertension is associated with increased activity of en¬
dogenous contractile agonists.
5.5 CONCLUSIONS
Na+/H+ antiporter activity in vitro has been found to be increased in
cells, including blood cells and vascular smooth muscle cells, in both
SHRs and patients with essential hypertension. It has now been shown
that Na+/H+ antiporter activity is also increased in skeletal muscle of
SHRs and that this increased Na+/H+ antiporter activity is present in
vivo.
There is growing evidence of a strong link between changes in cytoso-
lic calcium and changes in Na+/H+ antiporter activity in vascular
smooth muscle. From this work there is indirect biochemical evidence
that in vivo calcium metabolism is altered in the skeletal muscle of
SHRs, and this provides another link between altered Na+/H+ an¬
tiporter activity and altered calcium metabolism. Calcium could be
solely responsible for these changes in Na+/H+ antiporter activity or
Chapter 5 page 90
may amplify Na+/H+ antiporter activation in response to a given acti¬
vating stimulus.
It is also clear from this work that increased Na+/H+ antiporter activity
is found in association with increased relaxation of skeletal muscle
following contraction. Increased relaxation of vascular smooth muscle
following contraction has also been shown to occur in subcutaneous
arterioles obtained from patients with essential hypertension. Although
increased Na+/H+ antiporter may not be responsible for the increased
relaxation of muscle following contraction, these findings are against
the hypothesis that increased Na+/H+ antiporter activity is responsible
for increasing vascular smooth muscle contraction in hypertension.
It is likely, in view of increased vascular relaxation, that the cause of
increased vascular tone in hypertension is due to increased activity of
endogenous contractile agonists increasing cytosolic calcium and that
increased Na+/H+ antiporter activity occurs in association with or as a
secondary event resulting from these changes in calcium. Indeed, in¬
creased Na+/H+ antiporter may even be responsible for increasing vas¬
cular smooth muscle relaxation.
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Chapter six
Control of pH in the skeletal muscle of the spontaneously




The control of intracellular pH is essential for numerous cell func¬
tions, including cell division (Busa and Nucciteli, 1984; Grinstein et
al., 1989). Recently there has been growing interest in the way in
which the regulation of intracellular pH may be altered in hyperten¬
sion (Aalkjaer, 1990), and it has been proposed that altered pH regu¬
lation may be responsible for vascular hypertrophy in hypertension
(Lever, 1986).
The abnormalities in pH regulation that have been reported in asso¬
ciation with hypertension include abnormalities of Na+/H+ antiporter
activity in both spontaneously hypertensive rats (SHRs) and patients
with essential hypertension in vitro (Feig et al., 1986; Kuriyama and
Aviv, 1987; Canessa et al., 1988) and in SHRs in vivo (see Chapter
5). In addition, abnormalities of arterial pH, arterial bicarbonate
concentrations (Lucas et al., 1987), and bicarbonate handling by the
kidney (Lucas et al., 1988) have been demonstrated in young sponta¬
neously hypertensive rats (SHRs).
In Chapter 5 it was shown that there is evidence for increased
Na+/H+ antiporter activity in the skeletal muscle of SHRs in vivo.
However, in that study there was no determination of whether or not
intrinsic buffering or bicarbonate handling by skeletal muscle were
also different in SHRs in vivo.
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The aim of the work presented in this chapter was therefore to de¬
termine whether or not there was altered bicarbonate metabolism or
intrinsic buffering in adult SHRs in vivo. In order to do this changes
in cytosolic acid concentrations in skeletal muscle at rest and during
31
contraction were made using Phosphorus nuclear magnetic reso-
31
nance spectroscopy ( P NMR) after the administration of an in¬
hibitor of bicarbonate/chloride exchange and during variations in the




13-week old male SHRs and male WKY rats, ranging in weight from
250 g to 320 g, were obtained from Olac Ltd, Bicester, UK.
Anaesthesia was induced with pentobarbital sodium (30 mg/kg) and
was maintained during each experiment with halothane and nitrous
oxide (0.5-1.0% in 1:1 N20:02) delivered through a face-mask.The
flow of inhalational gas was kept constant at 3 1/min. The concentra¬
tion of inhaled carbon dioxide was varied to give carbon dioxide con¬
centrations of 0%, 6%, 14%, and 20%, balanced with nitrogen. The
inhaled carbon dioxide content was measured using mass spectrometry
(VG Mediflex Mass Spectrometer).
Mean arterial blood pressure was monitored by an indwelling catheter
in the external carotid artery. It was 125 (SD 8) mmHg in the WKY
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rats (n = 20) and 180 (SD 10) mmHg in the SHR (n = 20). There was
no significant change in the mean arterial pressure during increased
carbon dioxide inhalation.
The rats were prepared for stimulation of the plan-
taris/gastrocnemius/soleus muscle complex as previously described
(see Chapter 2). Sciatic nerve stimulation was performed on both
SHRs and WKY rats during inhalation of 20% carbon dioxide, after
allowing sufficient time for equilibration of carbon dioxide between
the blood and skeletal muscle. The time for equilibration was taken as
the time required for the intracellular pH to reach a constant value
after changing the carbon dioxide concentration of the inhaled gas.
Further groups of SHRs and WKY rats were given 0.2 mmol/kg of
4,4'-di-isothiocyanostilbene-2,2'-disulphonate (DIDS) (Sigma Chemic
-al Company Ltd, Dorset, England) 30 min before stimulation. After
DIDS the mean arterial pressure fell to 100 (SD 10; n=6) mmHg in
the WKY rats and 160 (SD 10; n=6) mmHg in the SHR.
6.22 Monitoring of arterial blood gases
Due to technical problems it was impractical to obtain arterial blood
from the animals whilst they were in the magnet, and so separate
groups of animals were subjected to identical protocols outside the
magnet. Samples of arterial blood (0.25 ml) were taken from the
carotid artery catheter at different times and the blood was analysed
immediately using a Radiometer ABL330 blood gas analyser, for pH,
Pa02, and PaC02 A maximum of 0.75 ml of blood was removed
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from each animal and this did not cause a change in mean arterial
pressure. The plasma bicarbonate concentration was calculated from
measured arterial pH and arterial PtfC02with the following
modification of the Henderson-Hasselbalch equation:
In this formula the C02 solubility coefficient (5) was taken as 0.0298
(Harned and Bonner, 1945) and the dissociation constant (pK) was
taken as 6.13 (Hastings and Sendroy, 1925)
6.23 NMR spectroscopy
Spectral parameters have been described previously (see Chapter 2).
A single resting spectrum was obtained using a tip angle of 90° at 0%
inhaled carbon dioxide and further resting spectra were obtained at
6%, 14%, and 20% inhaled carbon dioxide using a tip angle of 60°.
Spectra obtained during muscle contraction were all obtained using a
tip angle of 60°. Spectra were quantified by computer line-fitting, and
the pH was determined from the chemical shift of inorganic phosphate
(Pi) from phosphocreatine (PCr), which was nominally given a shift
of 0 p.p.m. (Moon and Richards, 1973). The acquisition trigger of the
spectrometer was gated such that 32 spectra were collected every 80 s.
The pH measurements thus obtained represented the average muscle
pH during sequential 80 s intervals of muscle contraction.
[HCO 3] = 5 x PC02 x 10 (pH pK) (1)
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6.24 Measurements of metabolite concentrations
The mean wet/dry weight ratio in muscle specimens was 4.4 (SD 0.2)
both at rest and after stimulation for 2 min. There were no statisti¬
cally significant differences in the mean wet/dry weight ratios during
20% carbon dioxide inhalation or after DIDS.
6.25 Calculation of intracellular bicarbonate concentra¬
tions
In calculating intracellular bicarbonate concentrations two assump¬
tions were made. Firstly, that when arterial PaC02 is at steady state
intracellular/><2C02 is also at steady state and is equivalent to arterial
PaC02 ; this is based on the fact that carbon dioxide has a high lipid
solubility, and so one would expect fast equilibration across cell
membranes. Second, that the dissociation constant for carbonic acid
(pK) in arterial blood is the same as the pK of carbonic acid inside
the cell; this is based on the fact that the pK of carbonic acid in any
solution is dependent on the absolute temperature and ionic strength
of the solution (Putman, 1988) and the fact that both the temperature
and ionic strength are likely to be the same in both arterial blood and
muscle cells.
Given these two assumptions it is possible to calculate the intracellu¬
lar bicarbonate concentration from a single measurement of intracel¬
lular pH using the values of the steady-state arterial PaCC>2 and the
pK for arterial blood in eqn (1). Thus, for the different inhaled
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carbon dioxide concentrations, it was possible to calculate
intracellular bicarbonate concentrations from the intracellular pH,
measured using 31P NMR, and the steady-state PaC02 measured in
arterial blood.
6.26 Calculation of buffering capacity in arterial blood and
skeletal muscle
Buffering capacity (P) is defined as the number of moles of hydrogen
ions ([H+ ions]) required to reduce intracellular pH (pHi) by one unit
(Van Slyke, 1922). It can be expressed by the following equation:
P = - A [H+]/ ApHi (2)
6.261 Buffering capacity at rest
Total buffering (Pt) in the muscle cell at rest consists of both
bicarbonate buffering (Pbicarb) and intrinsic buffering (pint)-
When the intracellular PaC02 is increased the hydrogen ion load to
the cell is also increased, and the change in intracellular pH as a
result of this hydrogen ion load is determined by Pint- As the
increase in hydrogen ion load to the muscle cell following an increase
in intracellular PaC02 is also equivalent to the increase in calculated
bicarbonate concentration, the Pint of the muscle cell can be
calculated from a plot of the changes in calculated bicarbonate
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concentration against the changes in intracellular pH resulting from
an increase in intracellular PaC02 , as shown in eqn (3).
Pint = -A [calculated bicarbonate]/ ApHi (3)
The same method can be used to calculate Pint for arterial blood. In
this study Pint was calculated for both SHRs and WKY rats for both
arterial blood and muscle. Pint was calculated from the slope of the
line, fitted by least squares linearization, relating the changes in
calculated mean intracellular and extracellular bicarbonate concen¬
trations to the changes in the measured mean intracellular and extra¬
cellular pH respectively at different steady-state values of PC02
(Aickin, 1977).
When the PaC02 is constant the contribution of bicarbonate to
buffering is also constant, and Pbicarb depends on the resting concen¬
tration of intracellular bicarbonate (Putman, 1988), as shown in eqn
(4)
Pbicarb = lnlO [HCOTl (4)
6.262 Buffering capacity during isometric contraction
During contraction there is a further contribution to muscle cell
buffering from phosphocreatine and phosphate (Wolfe et al., 1988).
This was assessed by measuring the changes in phosphocreatine and
31
phosphate concentrations by P NMR. during muscle contraction.
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6.27 Statistical and mathematical methods
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The data are presented as means (SD). Tests of normality were per¬
formed on all data (Royston, 1983) and one-way ANOVA was used
to compare all groups of rats, using Fisher's Protected Least
Significant Difference test. Areas under curves (AUCs) were
calculated using Simpson's method.
6.3 RESULTS
6.31 The effects of 20% inhaled carbon dioxide and DIDS
on changes in cytosolic acid concentrations during muscle
contraction
Fig. 6.1 shows the cytosolic acid response to isometric contraction in
untreated WKY rats and SHRs as shown in Chapter 5. In untreated
rats the cytosolic acid concentration rose to a maximum after 120 s of
stimulation and then returned to baseline concentrations, despite con¬
tinued stimulation. The AUC between 0 and 600 s was significantly
lower in the SHRs than in the WKY rats (P = 0.006). This difference
is removed by amiloride, an inhibitor of the Na+/H+ antiporter, which
also prevented the return to baseline cytosolic acid concentrations (see
Chapter 5).
Fig. 6.2 shows the cytosolic acid response in SHRs and WKY rats
during inhalation of 20% carbon dioxide. As in untreated rats, the
cytosolic acid concentration rose to a maximum after 120 s of
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stimulation and then returned to baseline concentrations, despite
continued stimulation. The AUC between 0 and 600 s was again
significantly lower in SHRs than in the WKY rats (P < 0.001). In
addition, the rate of return to baseline concentrations, has been
previously shown to be
Duration of sciatic nerve stimulation (s)
Fig. 6.1. The change in skeletal muscle cytosolic acid concentration
(pmolA) (mean with SEM; n=6) during 10 Hz isometric contraction in
untreated WKY rats (□) and untreated SHRs (■ ) {P = 0.006)
abolished by inhibition of Na+/H+ antiporter activity (see Chapter 5),
was unaltered by a high concentration of inhaled carbon dioxide.
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However, there was a significant increase in both groups of animals in
both the resting hydrogen ion concentration and the hydrogen ion
concentration after 600 s of contraction compared with untreated rats
(P < 0.001).
o
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Duration of sciatic nerve stimulation (s)
Fig. 6.2. The change in skeletal muscle cytosolic acid concentration
(pmol/1) (mean with SEM; n=6) during 10 Hz isometric contraction in
WKY rats (A) and SHRs (A) during 20% carbon dioxide (P < 0.001).
The administration of 0.2 mmol/kg DIDS before contraction (Fig.
6.3) had no effect on the cytosolic acid response compared to
untreated rats. DIDS did not produce a significant alteration in resting
cytosolic acid concentrations.
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6.32 Changes in concentrations of lactate, phosphocreatine,
inorganic phosphate, and ATP during contraction
Table 6.1 shows the concentrations of muscle lactate both at rest and
after 120 s of contraction during sciatic nerve stimulation under
different experimental conditions. Increased concentrations of inhaled
^ DIDS (0.2 mmol/kg)
Duration of sciatic nerve stimulation (s)
Fig. 6.3. The change in skeletal muscle cytosolic acid concentration
(p.mol/1) (mean with SEM; n=6) during 10 Hz isometric contraction in
WKY rats (o) and SHRs (•) after 0.2 mmol/kg DIDS (P < 0.001).
carbon dioxide resulted in a significant reduction in resting lactate
concentrations (P < 0.001), but DIDS had no effect. In contrast, both
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At rest After 120 s
WKY untreated 13.2 (3.7) 63.7 (7.9)
SHR untreated 14.3 (3.9) 64.6 (14.5)
WKY 20% C02 5.8 (3.4)* 95.7 (14.7)t
SHR 20% C02 6.2 (2.6)* 103.4 (24.2)f
WKY DIDS 12.5 (1.5) 97.1 (17.7)1*
SHR DIDS 11.0 (3.5) 105.3 (7.3)t
Values are shown as mean (SD); (n=6)
*P<0.001 compared with all unmarked values at 0 s (ANOVA using
Fisher's Protected Least Significant Difference test)
tP<0.001 compared with all unmarked values at 120 s (ANOVA
using Fisher's Protected Least Significant Difference test).
20% carbon dioxide and DIDS resulted in similar and significant
increases in muscle lactate concentrations at 120 s of contraction
(P < 0.001). These increases in muscle lactate concentration were not
significantly different between SHRs and WKY rats.
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Fig. 6.4 shows that there was no significant difference in both the
reduction and recovery of PCr, one of the most important buffers in
skeletal muscle cytosol (Wolfe et al., 1988), during sciatic nerve
stimulation in all groups of animals. Nor was there a significant dif¬
ference in the change in phosphate concentrations or in the fall in
ATP concentrations during contraction in the different groups of
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Fig. 6.4. The changes in skeletal muscle phosphocreatine (PCr)
concentrations (pmol/g dry weight) during 10 Hz isometric contraction
in untreated WKY rats (□) and SHRs (■ ), during 20% carbon dioxide
in WKY rats (A), and SHRs (A), and after 0.2 mmol/kg DIDS in WKY
rats (o), and SHRs (•). For clarity only the mean values are shown.
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6.33 Differences in bicarbonate concentrations and intrinsic
buffering between SHRs and WKY rats
Fig. 6.5 shows a plot of the mean arterial PC02 against the mean ar¬
terial and mean intracellular values of pH for both SHRs and WKY
rats. At increasing values of PC02 there were significant falls in both
intracellular pH and arterial pH. However, there was no significant










Mean arterial PaC02 (mmHg)
Fig. 6.5. The changes in arterial pH (dotted line) in SHRs (■- - -■)
and WKY rats (□- - -□) and the changes in intracellular pH (solid
line) in skeletal muscle of SHRs (• •) and WKY rats (o o) for
a given increase in arterial PC02 (Only mean values are shown)
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Fig. 6.6 shows the changes in calculated intracellular and extracellular
bicarbonate concentrations plotted against the changes in mean values
of intracellular and extracellular pH for different concentrations of
inhaled carbon dioxide in both SHRs and WKY rats. The intrinsic
buffering capacity calculated from these results was 55.5 mmol/l/pH
unit for SHRs and 47.6 mmol/l/pH unit for WKY rats. This difference



















Fig. 6.6. The changes in intracellular bicarbonate in SHRs (■ ■)
and in WKY rats (□- - -□) for a given increase in arterial PC02.
Mean values (SD); n=5.
The intracellular bicarbonate concentration in the SHRs at rest was
12.1 (SD 1.6) mmol/1, calculated from a measured intracellular pH of
7.05 (SD 0.02) and an arterial FC02of 44.7 (SD 6.7) mmHg. In
WKY rats the intracellular bicarbonate concentration was
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14.5 (SD 2.9) mmol/1, calculated from an intracellular pH of 7.04 (SD
0.02) and an arterial PC02of 58.1 (SD 8.9) mmHg. These differences
in intracellular pH and bicarbonate concentrations were not
statistically significant. There were also no significant differences at
rest in the values of arterial pH, PaC02, Pa02 and arterial bicarbonate
concentrations between SHRs and WKY rats.
6.4 DISCUSSION
In Chapter 5 pH regulation in skeletal muscle at rest and during con¬
traction in vivo in SHRs and WKY rats was studied using nuclear
magnetic resonance spectroscopy. Using this technique it was shown
that there is a significant difference in the cytosolic acid response in
skeletal muscle in SHRs compared with WKY rats during 10 Hz
isometric contraction, and since this difference was removed by prior
administration of amiloride, an inhibitor of the Na+/H+ antiporter,
this suggested that it was due to increased Na+/H+ antiporter activity
in vivo in SHRs.
However, in this previous study the role of bicarbonate in regulating
pH either at rest or during contraction was not determined. Nor was
the influence of bicarbonate exchange. Furthermore, amiloride,
which was used to define the activity of the Na+/H+ antiporter, has
actions other than antiporter inhibition (Frelin et al., 1987). In this
chapter the experiments described were performed in order to
investigate the role of bicarbonate and intrinsic intracellular
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buffering in the control of cytosolic pH and to determine whether or
not they are altered in hypertension.
In this work two methods were used to determine the contribution of
bicarbonate and intrinsic buffering to the control of pH in both rest¬
ing and contracting skeletal muscle in vivo and to determine whether
or not there was any evidence for altered bicarbonate handling in
skeletal muscle of the SHR. The role of intracellular bicarbonate was
studied by increasing the concentration of inhaled carbon dioxide
and the role of bicarbonate fluxes by the administration of DIDS, an
inhibitor of both sodium-dependent and sodium-independent bicar¬
bonate transport (Aickin, 1986; Kahn et al., 1990).
6.41 The effect of carbon dioxide and DIDS on cytosolic
acid concentrations during contraction
Neither carbon dioxide nor DIDS affected the difference in the
pattern of cytosolic acid changes during contraction between SHRs
and WKY rats. These results show that this difference in the cytosolic
acid response during contraction was not due to a difference in bi¬
carbonate exchange in the SHRs. The role of intracellular bicarbonate
in the control of resting pH is discussed below.
6.42 Intrinsic buffering in SHRs and WKY rats
The value of intrinsic buffering calculated in this study for skeletal
muscle in vivo for both SHRs and WKY rats is within the range of
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calculated values obtained from the literature for intrinsic buffering
of skeletal muscle (Aickin and Thomas, 1977b; Clancy and Brown,
1966; Heisler and Piiper, 1972). No significant difference was found
in the intrinsic buffering capacity between SHRs and WKY rats.
Since intrinsic buffering also includes resting Na+/H+ antiporter
activity, this implies that the increase in Na+/H+ antiporter activity
in SHRs at rest is not sufficient to result in a significant difference in
resting intrinsic buffering. This is discussed below in relation to
resting skeletal muscle intracellular pH in SHRs and WKY rats.
6.43 The effects of carbon dioxide and DIDS on skeletal
muscle metabolism in SHRs and WKY rats
Carbon dioxide and DIDS had no effect on the changes in the concen¬
trations of both phosphocreatine and inorganic phosphate both at rest
and during contraction. This is evidence that the intracellular
buffering caused by these compounds does not contribute to the dif¬
ference in cytosolic acid response during contraction between SHRs
and WKY rats.
Carbon dioxide caused a significant reduction in muscle lactate con¬
centrations at rest in both SHRs and WKY rats. The reason for this is
uncertain, but it could be that the resting acidosis resulting from the
carbon dioxide load inhibited phosphofructokinase activity and
reduced lactate formation (Trivedi and Danforth, 1966). Both carbon
dioxide and DIDS caused a significant increase in muscle lactate
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concentrations during contraction, but there was no difference
between SHRs andWKY rats.
6.44 The control of resting pH in the skeletal muscle of
SHRs and WKY rats
In the previous study (see Chapter 5) no significant difference was
found in cytosolic pH in resting skeletal muscle in SHRs compared
with WKY rats, despite evidence for increased Na+/H+ antiporter
activity in the skeletal muscle of the SHRs during contraction.
However, in the same study amiloride caused an equal acid shift in
the resting pH of the skeletal muscle of SHRs and WKY rats, suggest¬
ing that the Na+/H+ antiporter is active at rest in skeletal muscle (see
Chapter 5). There are three possible reasons for this combination of
findings. Firstly, as discussed in Chapter 5, it could be due to in¬
creased sodium-independent bicarbonate/chloride exchange, resulting
in increased bicarbonate efflux and preventing an alkaline shift in
resting pH in the SHRs. Secondly, it could be due to a reduction in
intrinsic buffering in the face of increased Na+/H+ antiporter activity
in SHRs compared with WKY rats. Thirdly, it could be that although
Na+/H+ antiporter activity is increased in SHRs, at rest this increase
in activity is too small to make a detectable difference in resting pH
compared with WKY rats.
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If a change in bicarbonate/chloride exchange were the explanation
for the lack of difference in resting values of intracellular pH,
inhibition of sodium-independent bicarbonate/chloride exchange by
DIDS in the presence of increased Na+/H+ antiporter activity in the
SHRs should have caused an alkaline pH shift at rest. However, DIDS
did not alter resting intracellular pH in either the SHRs or the WKY
rats. This result is evidence against the hypothesis that increased
sodium-independent bicarbonate/chloride exchange is responsible for
the finding of a lack of difference in resting values of intracellular
pH between SHRs and WKY rats.
6.442 The role of intrinsic intracellular buffering
There was no difference in this study in intrinsic buffering between
SHRs and WKY rats. Thus, a reduction in intrinsic buffering in the
SHRs cannot be responsible for the lack of difference in resting pH
in skeletal muscle between SHRs and WKY rats in the face of
increased Na+/H+ antiporter activity.
6.443 The role of the Na+/H+ antiporter
As discussed above intrinsic buffering capacity did not contribute to
the control of resting pH. Since intrinsic buffering includes the
resting activity of the Na+/H+ antiporter this implies that the increase
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in Na+/H+ antiporter activity in the SHRs is not sufficient to result in
a significant difference in resting intrinsic buffering.
To conclude therefore, the most likely reason for the finding that the
resting intracellular pH is the same in SHRs and WKY rats is that the
increase in Na+/H+ antiporter activity in the SHRs compared with
WKY rats is too small to make a detectable difference in resting pH.
Thus, any small difference in hydrogen ion load to the cell resulting
from a small increase in Na+/H+ antiporter activity is buffered by
intrinsic buffers and does not result in a detectable change in
intracellular pH.
However, it should be noted that perturbation of the bicarbonate
buffering system by a high concentration of inhaled carbon dioxide
altered resting intracellular pH (Fig. 6.2). This is compatible with the
in vitro finding that bicarbonate/chloride exchange is important in
regulating resting pH in skeletal muscle (Aickin, 1986). Since at
steady state bicarbonate influx equals bicarbonate efflux DIDS would
not be expected to alter net bicarbonate fluxes at rest, assuming that it
inhibits all bicarbonate transport systems (Aickin, 1986; Tpnnessen et
al., 1990; Kahn et al., 1990). Thus, the lack of effect of DIDS on
resting intracellular pH (Fig. 6.3) can be explained by the fact that it
inhibits both sodium-dependent bicarbonate/chloride exchange (which
results in bicarbonate influx) and sodium-independent bicarbon¬
ate/chloride exchange (which results in bicarbonate efflux).
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6.45 Bicarbonate handling in SHRs and WKY rats
It has been shown by others that in SHRs aged 6 to 12 weeks there
are significant reductions in arterial pH and bicarbonate concentra¬
tions and that bicarbonate clearance by the kidney is reduced com¬
pared with age-matched WKY rats (Lucas et al., 1987; Lucas et al.,
1988). However, in this study no significant differences were found
between SHRs and WKY rats in regard to arterial pH, arterial bicar¬
bonate concentrations, intracellular bicarbonate concentrations, intra¬
cellular pH, or intrinsic buffering. This implies that bicarbon¬
ate/chloride exchange at rest is the same in both groups of rats, and
therefore it cannot be concluded that bicarbonate metabolism in
skeletal muscle in SHRs is different from that in WKY rats.
One possible reason for the difference in the findings presented in
this chapter compared with that of previous workers (Lucas et al.,
1987; Lucas et al., 1988) could relate to the ages of the rats. In this
study 13-week-old adult rats were used whereas Lucas et al. used
younger rats (less than 12 weeks old). Thus, alterations in bicarbon¬
ate metabolism may be found only in the developing SHRs and not in
the adult SHRs with established hypertension.
6.46 The nature of the change in Na+/H+ antiporter
activity in vivo in the skeletal muscle of the SHR
In this study it has been shown that the difference in cytosolic acid
response during contraction between SHRs and WKY rats is not due
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to a difference in bicarbonate handling, intrinsic buffering, or
buffering from phosphocreatine or inorganic phosphate during con¬
traction. Na+/H+ antiporter activity is the only other mechanism
known to be responsible for pH regulation in muscle during contrac¬
tion, and this suggests that the difference in cytosolic acid response
seen in the presence of a high concentration of inhaled carbon diox¬
ide results from increased hydrogen ion efflux caused by an increase
in Na+/H+ antiporter activity in SHRs compared with WKY rats.
This result substantiates previous findings using amiloride (see
Chapter 5).
In Chapter 5 it was argued that the increase in Na+/H+ antiporter ac¬
tivity seen in SHRs resulted from an alkaline shift in the apparent Km
of the antiporter rather than an increase in its Vmax. An alkaline
shift in the Km of the antiporter would result in a reduced rate of
rise of cytosolic acid concentration and a reduced maximum cytosolic
acid concentration in SHRs, as demonstrated. At the maximum cy¬
tosolic acid concentration achieved, corresponding to a pH of 6.12,
the antiporter would be expected to be working at about 92% of its
Vmax if the Km is pH 7.16 in skeletal muscle cells, as has been
reported elsewhere (Vigne et al., 1985). Thus, the parallel fall in
cytosolic acid concentration to baseline after reaching a maximum in
SHRs and WKY rats is evidence that the Vmax of the Na+/H+ an¬
tiporter in vivo in skeletal muscle of the SHRs and WKY rats is the
same.
Chapter 6 page 115
If the assumption is made that the antiporter is working at the same
rate when cytosolic acid concentrations are at a peak in the SHRs as it
is in the WKY rats (i.e. 92% of maximum) it can be calculated that
the Km of the antiporter in the SHRs is around pH 7.33 in vivo. It
can also be calculated that at a resting intracellular pH of 7.05 in the
SHR the antiporter is 66% saturated. The corresponding value in the
WKY rats (resting intracellular pH 7.04 ) is 57%. In making these
calculations the assumption has also been made that there is no change
in the co-operativity or stoichiometry of the Na+/H+ antiporter
(Canessa et al., 1988).
6.5 CONCLUSIONS
In Chapter 5 work was presented which showed that during 10 Hz
isometric contraction of rat skeletal muscle there is a characteristic
pattern of change in cytosolic acid concentrations in vivo. In this
chapter further work has been presented which shows that this
pattern of cytosolic acid response is unaffected by 20% inhaled
carbon dioxide or by 4,4'-di-isothiocyanostilbene-2,2'-disulphonate
(DIDS). This is evidence that bicarbonate exchange in vivo is not
important in the control of cytosolic acid concentrations during
skeletal muscle contraction.
This work has also shown that the difference in cytosolic acid re¬
sponse during contraction between SHRs and WKY rats is due to in¬
creased Na+/H+ antiporter activity in SHRs. These current findings
suggest that this increase in Na+/H+ antiporter activity is more likely
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to be due to a change in the Km of the antiporter rather than to a
change in the Vmax, with a change in the Km of the antiporter in
hypertension from pH 7.16 to 7.33.
In contrast to the changes found during muscle contraction, there was
no evidence for increased Na+/H+ antiporter activity in the skeletal
muscle of SHRs at rest.
No differences were found between adult SHRs and WKY rats in re¬
gard to intrinsic buffering, resting intracellular and extracellular pH,
and resting intracellular and extracellular bicarbonate concentrations.
In addition, there was also no evidence of a difference in skeletal
muscle bicarbonate/chloride exchange between SHRs and WKY rats
or resting lactate concentration.
The lack of difference in resting intracellular pH between the two
types of rat, suggests that at rest differences in Na+/H+ antiporter
activity due to a shift in Km of the antiporter are too small to result
in a difference in resting pH.
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Chapter seven
The effect of isoprenaline and nifedipine on in vivo Na+/H+




In Chapters 5 and 6 it was shown that activity of the Na+/H+ antiporter
is increased in the skeletal muscle of the spontaneously hypertensive rat
in vivo. It was also shown that the Na+/H+ antiporter is the most impor¬
tant mechanism responsible for regulating cytosolic pH during contrac¬
tion-induced acidosis in skeletal muscle in vivo and this supports the
work of others in vitro (Aickin and Thomas, 1977a; Juel, 1988). The
work presented in this chapter is an extension of the work presented in
Chapters 5 and 6 and concerns the investigation of the mechanism re¬
sponsible for altering Na+/H+ antiporter activity in skeletal muscle.
Catecholamine release accompanying extracellular acidosis attenuates the
reduction in cytosolic pH in both skeletal and cardiac muscle (Clancy et
al., 1976). Furthermore, P-adrenoceptor agonists enhance the calcium
current mediated by L-type calcium channels in skeletal muscle (Arreola
et al., 1987). In view of these findings and the important role Na+/H+ ex¬
change has in controlling acidosis in skeletal muscle, the hypothesis was
proposed that one action of catecholamines on skeletal muscle was to in¬
crease skeletal muscle Na+/H+ antiporter activity. In addition, it was also
felt possible that opening of L-type calcium channels in skeletal muscle
could be linked to Na+/H+ antiporter activation in skeletal muscle.
31 31In this work Phosphoms nuclear magnetic resonance spectroscopy ( P
NMR) was again used to study Na+/H+ antiporter activity in the plan-
taris/gastrocnemius/soleus group of muscles in a rat leg during 10 Hz
isometric contraction as described in chapters 2,5 and 6. In addition, the
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effect of the (^-adrenoceptor agonist isoprenaline and the effect of a spe¬
cific L-type calcium channel blocker, the dihydropyridine calcium antag¬




13-week old male Wistar-Kyoto (WKY) rats ranging in weight from
200 g to 290 g, obtained from Olac Ltd, Bicester, UK were studied.
Anaesthesia was induced with pentobarbitone sodium (30 mg/kg) and
was maintained during each experiment with halothane (0.5-1.0 % in
1:1 N20:02) delivered through a face-mask. Sciatic nerve stimulation
was used to cause contraction of the plantaris, gastrocnemius, and
soleus muscles as a group.The method of preparing the rats for stimu¬
lation of the plantari/gastrocnemius/soleus muscle complex has been de¬
scribed previously (see Chapter 2).
Isoprenaline (0.1 mmol/kg) was used as a (32-adrenoceptor agonist,
nifedipine (0.8 mg/kg) as an L-type calcium channel antagonist, and
amiloride (0.4 mmol/kg) as an inhibitor of the Na+/H+ antiporter. The
drugs were given intra-arterially 30 min before muscle contraction.
The mean arterial pressure fell to 60 (SD 5) mmHg after all drug
treatments. In order to examine whether or not this hypotension was
responsible for the observed changes in cytosolic acid responses we
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lowered the BP to 60 (SD 7) mmHg in a further group of animals by




7.23 Measurements of metabolite concentrations
(see Chapter 2)
7.24 Statistical and mathematical methods
Tests of normality were performed on all data (Royston, 1983) and
one- way ANOVA was used to analyse the data, using Dunnett's method
to compare data obtained for the different drug treatments with un¬
treated rats and Fisher's Protected Least Significant Difference test to
compare the different drug treatments. Areas under curves (AUCs)




7.31 The effects of isoprenaline, nifedipine, and amiloride
on changes in cytosolic acid concentration during muscle
contraction
Fig. 7.1a shows the cytosolic acid response to isometric contraction in
untreated rats and in rats given amiloride (0.4 mmol/kg). In untreated
rats the cytosolic acid concentration rose to a maximum after 120 s of
stimulation and then returned to baseline, despite continued stimulation.
Inhibition of the Na+/H+ antiporter by amiloride prevented this return to
baseline.
Figs. 7.1b and 7.1c show the cytosolic acid responses to isoprenaline (0.1
mmol/kg) and nifedipine (0.8 mg/kg). Isoprenaline caused a significant
reduction in both the peak cytosolic acid concentration achieved
(P < 0.001) and the AUC between 0 and 600 s during isometric
contraction (P < 0.001) compared with the untreated rats. In contrast,
nifedipine did not significantly change either the maximum cytosolic acid
concentration or the AUC between 0 and 600 s compared to untreated
rats. However, the return to baseline acid concentrations was slower and
the baseline acid concentration achieved during contraction was
significantly greater than in untreated rats (P < 0.001).
Both isoprenaline and nifedipine produced the same fall in arterial BP to
60 mmHg. Animals bled to the same mean BP produced a significant re¬
duction in the maximum cytosolic acid concentration achieved
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(.P < 0.001) compared with untreated rats, although comparison of the
AUC between 0 and 600 s did not reach significance (Fig. 7.Id). Bleeding
did not affect the rate of return to baseline acid concentrations and the
baseline acid concentrations achieved were not significantly different
from untreated rats.
Fig. 7.1e shows the cytosolic acid response after administration of the
combination of isoprenaline (0.1 mmol/kg) and nifedipine (0.8 mg/kg)
before contraction. This combination caused a significant reduction in the
maximum cytosolic acid concentration achieved (P < 0.001) and a signifi¬
cant reduction in the AUCs between 0 and 600 s compared with untreated
rats (P < 0.004) but not compared with rats given only isoprenaline.
However, after the combination of nifedipine and isoprenaline the rate of
return to baseline acid concentrations was again slower and the baseline
acid concentrations achieved were greater than after isoprenaline on its
own (P < 0.001).
Fig. 7.If shows the effect of nifedipine in isolation and in combination
with isoprenaline. In both cases there was a significant reduction in the


























0 200 400 600 800 1000 1200
(b)




















o 0.0-1 ■ T
0 200 400
i ■ 1 ■ 1 > 1
600 800 1000 1200





0 200 400 600 800 1000 1200
Duration of sciatic nerve stimulation (s)
800 1000 1200









































0 200 400 600 800 1000 1200
Duration of sciatic nerve stimulation (s)
1.01
t ' 1 1 1 ' r
0 200 400 600 800 1000 1200
Duration of sciatic nerve stimulation (s)
Chapter 7 page 126
Fig. 7.1a-f. Changes in skeletal muscle cytosolic acid concentration
(|iM) (Mean ± SEM; n=6) during 10Hz isometric contraction in: (a)
(o) untreated rats and (•) rats after amiloride (0.4mmol/kg) adminis¬
tration, (b) (o) untreated rats and (■) rats after isoprenaline (0.1
mmol/kg) administration, (c) (o) untreated rats and (A) rats after
nifedipine (0.8 mg/kg) administration, (d) (o) untreated rats and (□)
rats after a 2.5 ml bleed, (e) (o) untreated rats and (A) rats after both
isoprenaline (0.1 mmol/kg) and nifedipine (0.8 mg/kg) administration,
(f) (A) rats after nifedipine (0.8 mg/kg) administration and
(A) rats after both 0.1 mmol/kg isoprenaline and 0.8 mg/kg nifedipine
administration.
7.32 Changes in lactate, phosphocreatine, inorganic phos¬
phate, and ATP during contraction
Table 7.1 shows the concentrations of muscle lactate at 0 and 120 s of
contraction during sciatic nerve stimulation. Isoprenaline both alone and
in combination with nifedipine resulted in a significant increase in resting
muscle lactate concentrations compared with untreated rats (P < 0.001)
and with rats given nifedipine alone (P < 0.001). Isoprenaline, nifedipine,
and bleeding all resulted in significant increases in muscle lactate concen¬
trations at 120 s of stimulation compared with untreated rats (P < 0.001).
However, there was no significant difference in the increase in lactate
concentrations in these different groups of animals. In contrast, treatment
with amiloride (0.4 mmol/kg), which also caused a reduction of mean BP
to 60 mmHg, did not result in an increase in muscle lactate concentrations
compared to untreated rats.
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Table 7.1. Muscle lactate (|imol/g dry weight) at rest and after
120 s isometric stimulation
Muscle lactate
Condition at rest after 120 s
untreated 13.2 (3.7) 63.7 (3.2)
after amiloride 12.8 (1.2) 57.6 (3.6)
after isoprenaline 18.5 (3.4)* 117.3 (7.6)t
after nifedipine 13.2 (2.8) 104.4 (7.5)t
after a 2.5 ml bleed 12.4 (1.5) 97.4 (5.3)t
after isoprenaline and 20.5 (3.7)* 113.5 (15.l)f
nifedipine
Values are shown as mean (SD); (n=6)
*P < 0 001 compared with all unmarked values at 0 s (ANOVA with
Dunnett's test), < 0.001 compared with all unmarked values at 120 s
(ANOVA with Dunnett's test)
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Fig. 7.2 shows that there was no significant difference in both the reduc¬
tion and recovery of PCr during sciatic nerve stimulation in all groups of
animals. There were also no significant differences in the change in Pt or
the fall in ATP during contraction in the different groups of animals (data
not shown). Both PCr and Pj act as important buffers in muscle cytosol
during contraction (Wolfe et al., 1988).
Duration of sciatic nerve stimulation (s)
Fig 7.2 The change in skeletal muscle phosphocreatine (PCr) concen¬
tration (pmol/g dry weight) during 10 Hz isometric contraction in (o)
untreated rats (Mean ± SD; n=6) and the mean values (n=6) of rats after
administration of: (•) amiloride (0.4 mmol/kg), (■) isoprenaline
(0.1 mmol/kg), (A) nifedipine (0.8 mg/kg), (A) isoprenaline
(0.1 mmol/kg) and nifedipine (0.8 mg/kg), and (□) after a 2.5 ml bleed.
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7.33 Changes in twitch tension during contraction
Figs. 7.3a-f show the twitch tension response produced by the contracting
skeletal muscle during 10 Hz isometric contraction. Stimulation at this
frequency results in summation of contraction and partial tetanus, due to a
build up of cytosolic calcium during contraction (Fig.7.3a). After
amiloride relaxation between twitches was abolished (Fig. 7.3b).
Figs. 7.3c to 7.3f show that isoprenaline, nifedipine, and bleeding before
contraction increased the relaxation between twitches and reduced the
summation of contraction (P < 0.001).
7.4 DISCUSSION
As shown in chapters 5 and 6 the pattern of changes in cytosolic acid con¬
centrations during skeletal muscle contraction can be used to study
Na+/H+ antiporter activity, which is the most important mechanism for
controlling acid response during contraction. This result is emphasized
here by the effect of amiloride, an inhibitor of the Na+/H+ antiporter
(Fig. 7.1a). In this work this technique has been used to study the effects
of isoprenaline and nifedipine on in vivo Na+/H+ antiporter activity.
The effect of isoprenaline on Na+/H+ antiporter activity
Stimulation of p2"adrenoceptors by isoprenaline reduced the maximum
cytosolic acid concentration achieved during contraction (Fig. 7.1b), de¬
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effect was not attributable to the lowering of blood pressure caused by
isoprenaline, since the effect of isoprenaline was significantly greater than
the effect produced by bleeding to the same BP (Fig. 7.Id) (P < 0.001).
Thus, this finding is consistent with an increase in Na+/H+ antiporter
activity in skeletal muscle in response to P2-adrenoceptor stimulation.
As (^-adrenoceptor stimulation results in an increase in the concentra¬
tions of cyclic AMP in skeletal muscle, it is likely that a cyclic-AMP-
dependent process is responsible for this increase in Na+/H+ antiporter
activity. This is consistent with the finding that activation of a cyclic-
AMP-dependent kinase increases Na+/H+ antiporter in frog erythro¬
cytes (Borgese et al., 1987), although not with the finding that it in¬
hibits the Na+/H+ antiporter in lymphocytes (Grinstein and Cohen,
1987).
7.42 The effect of nifedipine on Na+/H+ antiporter activity
In contrast to isoprenaline, nifedipine did not reduce the maximum cy-
tosolic acid concentration, although it did reduce the rate of return to
baseline during continued contraction. Furthermore, the fall in maximum
cytosolic acid concentrations which occurred during contraction in ani¬
mals who had been bled did not occur in the animals treated with
nifedipine, despite the fact that the BP was the same in the two groups of
animals.
The return of cytosolic acid concentrations to baseline during contraction
was partially attenuated by nifedipine. Since this return to baseline, which
is completely blocked by amiloride (Fig. 7.1a), is attributable to the
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activity of the Na+/H+ antiporter (see Chapter 5 and 6) this result is
consistent with a requirement of calcium for the full activation of the
antiporter in skeletal muscle. This result is also consistent with the in
vitro finding that in vascular smooth muscle calcium is required for full
activation of the Na+/H+ antiporter (Mitsuhashi and Ives, 1988).
Furthermore, since the action of nifedipine as a calcium antagonist is
specific to the L-type calcium channel (Flockerzi et al., 1986; McCall,
1987), this result suggests that one function of the L-channel in skeletal
muscle is the provision of calcium for Na+/H+ antiporter activation.
7.43 The effect of bleeding on Na+/H+ antiporter activity
Hypotension secondary to bleeding caused a reduced maximum cytosolic
acid response during contraction, despite an increased muscle lactate con¬
centration. This suggests that hypotension induced by a bleed is also asso¬
ciated with an increase in Na+/H+ antiporter activity in skeletal muscle
Somatic nerves to skeletal muscle also contain sympathetic nerve fibres
(Sundlof et al., 1977). It has also been shown that hypotension due to
bleeding results in increased sympathetic neuronal discharge in these
nerves (Green and Heffron, 1966). It is likely therefore that the explana¬
tion for the decreased acid response during contraction seen in this study
after a bleed results from an increase in Na+/H+ antiporter activity due to
increased sympathetic discharge to skeletal muscle, resulting in increased
[^-adrenoceptor stimulation. This may also be one of the mechanisms re¬
sponsible for the well-known but poorly understood "fright and flight"
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response, since it is likely that increased sympathetic discharge to skeletal
muscle prepares an animal for muscle contraction and flight by increasing
Na+/H+ antiporter activity and H+ ion efflux.
7.44 Differences in contractile responses after amiloride,
isoprenaline, nifedipine, and bleeding
During contraction of skeletal muscle there are large increases in cytoso-
lic calcium, and the two main mechanisms responsible for the bulk re¬
moval of calcium from the cytosol are the sarcolemmal Na+/Ca++ ex¬
changer and Ca++-ATPase activity in the sarcoplasmic reticulum
(Carafoli, 1987; Carafoli, 1988). Of the two, Ca++-ATPase activity is
thought to be the more important. At a sciatic nerve stimulation of 10 Hz
used in this study there is summation of muscle contraction. This suggests
that the mechanisms for controlling cytosolic calcium have been over¬
come, leading to accumulation of calcium during contraction and summa¬
tion of contraction.
Amiloride produced almost complete inhibition of relaxation between
twitches. The mechanism for this is uncertain but it is known that
amiloride in high concentrations inhibits not only Na+/H+ antiporter ac¬
tivity but also Na+/Ca++ exchange and Na+/K+-ATPase activity (for re¬
view see Frelin et al., 1987).Thus, inhibition of Na+/Ca++ exchange and
Na+/K+-ATPase activity may be the cause of the reduced relaxation after
amiloride.
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In contrast to amiloride, isoprenaline, nifedipine, and bleeding ail caused
a significant increase in relaxation between twitches and a reduced maxi¬
mum generated tension in the muscle during contraction. The mechanism
responsible for this increased relaxation is also uncertain but it is possible
that this could be a cyclic-AMP-dependent process, as isoprenaline,
nifedipine, and bleeding would all be expected to increase concentrations
of cyclic-AMP. However, this is unlikely to involve a cyclic-AMP-de-
pendent increase in sarcoplasmic Ca++-ATPase activity as shown in my¬
ocardium (Limas and Spier, 1980), because there is no evidence for such
a mechanism in skeletal muscle (Stull, 1980). Nevertheless, an increased
cyclic-AMP concentration could increase Na+/K+-ATPase activity in
skeletal muscle (Clausen, 1986) and increase relaxation by increasing the
rate of repolarization following contraction.
There was no relationship between increased muscle relaxation during
contraction and changes in cytosolic pH in the pH range 6.10 - 7.04. This
suggests that in skeletal muscle changes in pH in this range have little ef¬
fect on the action of calmodulin in regulating Ca++-ATPase activity
(Carafoli, 1987).
7.45 Changes in skeletal muscle metabolism after amiloride,
nifedipine, isoprenaline, and bleeding
Amiloride had no effect on skeletal muscle concentrations of lactate dur¬
ing contraction, in contrast to nifedipine, isoprenaline, and bleeding, all
of which increased muscle lactate concentrations during contraction
(Table 7.1).
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The difference between the effects on skeletal muscle lactate of amiloride
on the one hand and of nifedipine, isoprenaline, and bleeding on the other
hand may be due to inhibition of adenylate cyclase by amiloride (Mahe et
al., 1985), since the other stimuli would all be expected to stimulate
adenylate cyclase and increase cyclic-AMP concentrations. These results
also show that differences in lactate production could not explain the dif¬
ferences in acid responses to nifedipine, isoprenaline, and bleeding (Figs
7.1a-f).
None of the stimuli used caused any changes in the utilization of skeletal
muscle PCr (Fig. 7.2) or changes in Pj during contraction. This suggests
that the differences in acid responses during contraction are not due to
major differences in intracellular buffering from changes in Pj and PCr.
7.45 CONCLUSIONS
This work has shown that p2-adrenoceptor stimulation increases the ac¬
tivity of the Na+/H+ antiporter in vivo in skeletal muscle. It has also
shown that opening of the L-type calcium channel is necessary for full
activation of the Na+/H+ antiporter in skeletal muscle in vivo.
Furthermore, relaxation between twitches in skeletal muscle is increased
in conditions that would be expected to increase cyclic-AMP and over the
pH range 6.10 - 7.04 is not greatly affected by changes in pH.
Bleeding also causes an increase in the activity of the Na+/H+ antiporter
in vivo in skeletal muscle. This is most likely to be due to an increase in
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sympathetic nerve outflow to skeletal muscle as a result of hypotension.
Thus, as part of the "fright and flight" reaction, this may be one of the
mechanisms by which animals under stress prepare their skeletal muscle
for exercise.
This work also has implications for the mechanism responsible for the
finding of increased Na+/H+ antiporter activity in the skeletal muscle of
SHRs (see Chapters 5 and 6). It is most likely that the increased Na+/H+
antiporter activity in skeletal muscle of SHRs is due to increased sympa¬
thetic nervous activity and increased (^-adrenoceptor stimulation.
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Chapter eight
The effect of nifedipine on in-vivo Na+/H+ antiporter




Increased Na+/H+ antiporter activity has been found in blood cells and
in vascular smooth muscle cells obtained from SHRs (Feig et al., 1987;
Feig et al., 1986; Kuriyama and Aviv, 1987) and in blood cells obtained
from patients with essential hypertension (Canessa et al., 1988; Livne et
al., 1987). The finding of increased Na+/H+ antiporter activity in hy¬
pertension has led to the hypothesis that this increase may be responsi¬
ble for the vascular smooth muscle hyperplasia and vascular remod¬
elling which are important in the maintenance of increased blood pres¬
sure in patients with essential hypertension (Lever, 1986). The hypoth¬
esis that increased Na+/H+ antiporter is responsible for these changes in
the vascular smooth muscle of SHRs and patients with essential hyper¬
tension stems from the finding that cell mitogens have been shown to
increase Na+/H+ antiporter activity (Moolenar et al., 1982; Pouyssegur
et al., 1982). In addition, Na+/H+ antiporter activity has also been
shown to increase with noradrenaline (Aalkjaer and Cragoe, 1988) and
angiotensin II (Berk et al., 1987a), which are known to cause vascular
smooth muscle hyperplasia.
31
In Chapters 5-7 Phosphorus nuclear magnetic resonance spectroscopy
31
( P NMR) was used to make in-vivo measurements of cytosolic pH
during 10 Hz isometric contraction of the plantaris/gastrocnemius/
soleus group of muscles in a rat leg and it was found that the pattern of
change in cytosolic pH during contraction is determined by Na+/H+ an¬
tiporter activity. This confirms the findings of others in vitro, that hy¬
drogen ion efflux via the Na+/H+ antiporter is the most important
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mechanism for controlling cytosolic pH in skeletal muscle (Aicken and
Thomas, 1977). This method was used to assess Na+/H+ antiporter ac¬
tivity in the skeletal muscle of both SHRs and normotensive WKY rat
controls and showed that Na+/H+ antiporter activity is increased in the
skeletal muscle of SHRs in vivo, confirming in-vitro findings (see
Chapters 5 and 6).
Work using cell mitogens suggests that there is a close association be¬
tween increased cytosolic calcium and increased Na+/H+ antiporter ac¬
tivity (Busa and Nuccitelli, 1984), and in human fibroblasts stimulation
of Na+/H+ antiporter by growth factors is blocked by calcium antago¬
nists and calmodulin antagonists (Owen and Villereal, 1982). In hyper¬
tension, cells also demonstrate altered calcium handling and increased
Na+/H+ antiporter (Postnov and Orlov, 1985). This has led to the hy¬
pothesis that an increase in cytosolic calcium concentration could in
part be responsible for an increase in Na+/H+ antiporter activity in
hypertension (Aviv, 1988). In support of this hypothesis it has been
shown that in vascular smooth muscle cells full activation of the Na+/H+
antiporter by protein kinase C-dependent and independent pathways re¬
quires calcium (Mitsuhashi and Ives, 1988). In addition, there have
been several reports that cytosolic calcium is raised in cells obtained
from SHRs (Eme et al., 1984) and patients with essential hypertension
(Astaire et al., 1989; Lindner et al., 1987). These same cells have been
shown to have increased Na+/H+ antiporter activity (Feig et al., 1987;
Feig et al., 1986; Kuriyama and Aviv, 1987; Canessa et al., 1988; Livne
et al., 1987; Lever, 1986).
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However, raised cytosolic calcium is not a uniform finding in associa¬
tion with hypertension (Nabika et al., 1985; Bukoski, 1990; Pritchard et
ah, 1989). Furthermore, the small increase in cytosolic calcium that has
been reported in cells obtained from both SHRs and patients with
hypertension would not necessarily explain the increased Na+/H+
antiporter activity found in vascular smooth muscle, as a much larger
increase in cytosolic calcium would appear to be required for alteration
of Na+/H+ antiporter activity in vascular smooth muscle cells
(Mitsuhashi and Ives, 1988). Thus, even if cytosolic calcium is
increased in cells obtained from hypertensive animals and humans this
may still not explain the increased Na+/H+ antiporter activity found in
association with hypertension.
However, cells obtained from hypertensive animals and humans which
demonstrate increased Na+/H+ antiporter activity have shown a consis¬
tent increase in calcium influx via L-type calcium channels (Postnov
and Orlov, 1985; Rusch and Hermsmeyer, 1988). It was considered
therefore whether this increased calcium influx via potential operated
calcium channels could, by leading to a local increase in calcium con¬
centration at the plasma membrane (Carafoli, 1987), result in increased
_j_ _j_ o 1
membrane Na /H exchange in hypertension. To test this hypothesis P
NMR was used to measure in-vivo Na+/H+ antiporter activity and
nifedipine, a specific L-type calcium channel antagonist, was used to
determine the effect of blockade of L-type calcium channels on in-vivo





13-week old male SHRs and age-matched male WKY in-bred controls,
ranging in weight from 240 g to 312 g, were obtained from Olac Ltd,
Bicester, UK. Anaesthesia was induced with pentobarbital sodium (30
mg/kg) and was maintained during each experiment with halothane
(0.5-1.0 % in 1:1 N20:02) delivered through a face-mask.
The method of preparing the rats for stimulation of the plan-
taris/gastrocnemius/soleus muscle complex has already been described
(see Chapter 2). In experiments with nifedipine (Bayer U.K. Ltd) the
drug was injected intra-arterially in a dose of 0.8 mg/kg 30-40 min be¬
fore sciatic nerve stimulation.
Mean arterial pressure was monitored by an indwelling catheter in the
external carotid artery and was 120 (SD 9) mmHg in the WKY rats (n
= 20) and 185 (SD 9) mmHg in the SHRs (n = 20). The mean arterial
pressure fell to 80 mmHg (SD 5; n = 6) in SHRs and 60 mmHg (SD 5; n
= 6) after nifedipine. In order to determine whether or not hypotension
was responsible for the observed changes in cytosolic acid responses the
BP was lowered to 80 mmHg (SD 5; n=6) and 60 (SD 7; n=6) mmHg in
further groups of SHRs and WKY rats respectively by removing ap¬





8.23 Measurements of metabolite concentrations
(see Chapter 2)
8.24 Statistical and mathematical methods.
The data are presented as means (SDs). Tests of normality were per¬
formed on all data (Royston, 1983) and one-way ANOVA was used to
compare all groups of rats, using Fisher's Protected Least Significant
Difference test. Areas under curves (AUCs) were calculated using
Simpson's method.
8.3 RESULTS
8.31 The effects of nifedipine and bleeding on changes in
cytosolic acid concentrations during muscle contraction.
Fig. 8.1a shows the cytosolic acid response to isometric contraction in
untreatedWKY rats and SHRs. In untreated rats the cytosolic acid con¬
centration rose to a maximum after 120 s of stimulation and then re¬
turned to baseline concentrations, despite continued stimulation. The
AUC between 0 and 600 s was significantly lower in the SHRs than in
the WKY rats (P = 0.006). It has previously been shown that this dif-
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ference is removed by amiloride, an inhibitor of the Na+/H+ antiporter
(see Chapter 5), which also prevented the return to baseline cytosolic
acid concentrations.
Fig. 8.1b shows the cytosolic acid response in SHRs and WKY rats after
nifedipine (0.8 mg/kg). Nifedipine removed the difference in AUC
between untreated SHRs and untreated WKY rats. Nifedipine did not
prevent the return to baseline concentrations of cytosolic acid but the
rate of return to baseline acid concentrations was slower and the base¬
line acid concentration achieved during continued contraction was sig¬
nificantly higher than in untreated SHRs and WKY rats (P < 0.001).
The BPs of the animals before treatment were 120 (9) mmHg in the
WKY rats (n = 20) and 185 (9) mmHg in the SHRs (n = 20). Nifedipine
produced a fall in mean arterial BP to 80 mmHg in the SHRs and to 60
mmHg in the WKY rats. The removal of 2.5 ml of blood resulted in
similar falls in BP. However, in contrast to the effects of nifedipine
(Fig. 8.1b), lowering the BP in this way did not remove the difference
between the SHRs and WKY rats in the pattern of the cytosolic acid
concentration changes during contraction, which remained significant
(P< 0.003) (Fig. 8.1c).
When rats were bled before contraction the maximum cytosolic acid
achieved in both SHRs and WKY rats was reduced (P < 0.001).
However, in contrast to rats given nifedipine before contraction, reduc¬
ing the blood pressure by bleeding did not affect either the rate of
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(c)
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Fig. 8.1 The change in skeletal muscle cytosolic acid concentration
(pM) (Mean with SEM; n=6) during 10 Hz isometric contraction in (a)
untreated WKY rats (□) and untreated SHRs (B)(Fig. 5.1a), (b) WKY
rats (o) and SHRs (•) after nifedipine (0.8 mg/kg), and (c) WKY rats
(A) and SHRs (A) after a 2.5 ml bleed.
return to baseline acid concentrations or the baseline acid concentration
achieved during continued contraction.
8.32 Changes in lactate, phosphocreatine, inorganic phos¬
phate, and ATP concentrations during contraction
Table 8.1 shows the concentrations of muscle lactate both at rest and
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different experimental conditions. Both nifedipine and bleeding before
contraction resulted in similar and significant increases in muscle lac¬
tate concentrations (P < 0.001). However, this increase in muscle lac¬
tate concentration was not significantly different between SHRs and
WKY rats.
Fig. 8.2 shows that there was no significant difference in both the re¬
duction and the recovery of PCr during sciatic nerve stimulation in all
groups of animals. There was also no significant difference in the
change in Pj or the fall in ATP concentrations during contraction in the
different groups of animals (data not shown). Both PCr and Pi act as
important buffers in muscle cytosol during contraction (Wolfe et al.,
1988).
8.33 Changes in twitch tension during contraction.
Figs. 8.3a-f. show the typical twitch tension responses produced by the
contracting skeletal muscle during 10 Hz isometric contraction in un¬
treated WKY rats (Fig. 8.3a), untreated SHRs (Fig. 8.3b), WKY rats
after nifedipine (Fig.8.3c), SHRs after nifedipine (Fig.8.3d), WKY rats
after a 2.5 ml bleed (Fig. 8.3e), and SHRs after a 2.5 ml bleed (Fig.
8.3f). Stimulation at 10 Hz results in summation of contraction and
partial tetanus, due to a build up of cytosolic calcium during contrac¬
tion. The untreated SHRs showed increased relaxation between twitches
and a reduced maximum generated tension compared with untreated
WKY rats (P < 0.001), as has been previously shown (see Chapter 5).
Both nifedipine and bleeding before contraction increased the degree of
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relaxation between twitches and reduced the maximum tension gener¬
ated by WKY rats (P < 0.001).
0 H ' 1 ■ 1 ■ 1 ■ 1
0 200 400 600 800
Duration of sciatic nerve stimulation (s)
Fig. 8.2 The changes in skeletal muscle phosphocreatine (PCr)
concentrations (pmol/g dry weight) during 10 Hz isometric contraction
in (□) untreated WKY rats, (■) untreated SHRs, (o) WKY rats after
nifedipine (0.8 mg/kg), (•) SHRs after nifedipine (A) WKY rats after a
2.5 ml bleed and (A) SHRs after a 2.5 ml bleed. For clarity only the








































































As has been shown in previous chapters the pattern of changes in cy-
tosolic acid concentrations during skeletal muscle contraction can be
used to study Na+/H+ antiporter activity. (For the sake of clarity some
of the data presented in Chapter 5 has been reproduced ie. Fig. 8.1a) In
Chapter 5 it was shown that there is a significant difference in the cy-
tosolic acid response in skeletal muscle in SHRs compared with WKY
rats during 10 Hz isometric contraction, and that this difference is at¬
tributable to an increase in the activity of the Na+/H+ antiporter. In this
study this technique has been used to delineate the role of L-type cal¬
cium channels in in-vivo Na+/H+ antiporter activity in the SHR, using
nifedipine as a specific antagonist at those channels.
8.41 The effect of nifedipine on in-vivo Na+/H+ antiporter
activity
After nifedipine the difference between the cytosolic acid responses in
SHRs and WKY rats during contraction were no longer seen (Fig.
8.1b). This effect of nifedipine was not due to the fact that it caused hy¬
potension, since the difference in the patterns of cytosolic acid re¬
sponses between SHRs andWKY rats was not removed in animals that
had been bled to the same BP (Fig. 8.1c).
Although nifedipine did not prevent the eventual return of cytosolic
acid to baseline concentrations it did slow the rate of return. As the re¬
turn to baseline cytosolic acid concentrations during continued contrac-
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tion is determined by Na+/H+ antiporter activity (see Chapter 5), this
result suggests that increased calcium influx via the opening of L-type
calcium channels is required for full activation of the Na+/H+
antiporter in vivo. Furthermore, blockade of the L-type channel
removed the difference in the cytosolic acid response between SHRs and
WKY rats, and this suggests that the finding of increased Na+/H+
antiporter activity (see Chapters 5 and 6) in the skeletal muscle of the
SHR is secondary to increased calcium influx via L-type calcium
channels. In addition, as increased calcium influx via L-type calcium
channels has been demonstrated in vascular smooth muscle cells
obtained from SHRs compared with WKY rats (Rusch and
Hermsmeyer, 1988), it is possible that increased calcium influx could
also be the mechanism responsible for the increase in Na+/H+ antiporter
activity found in vascular smooth muscle in hypertension.
If the increase in Na+/H+ antiporter activity in skeletal muscle in SHRs
is due to increased calcium influx it could result from a local increase
in the concentration of calcium at the cell membrane rather than a gen¬
eralized increase in cytosolic calcium concentration (Carafoli, 1987).
Indeed, it is unlikely that even a moderate increase in calcium influx
into the muscle cell would result in a generalized increase in the cy¬
tosolic calcium concentration, because the amount of calcium entering
the muscle cell via the L-type calcium channels is small (of the order of
nmol) and the capacity of the muscle cell to remove calcium from the
cytosol into sarcoplasmic reticulum is very large (of the order of
mmol) (Carafoli, 1987; Carafoli, 1988).
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8.42 The effect of reducing blood pressure by bleeding on
in-vivo Na+/H+ antiporter activity
Hypotension secondary to bleeding caused a reduced maximum cytoso-
lic acid response during contraction in both groups of animals, despite
an increased muscle lactate concentration. This suggests that hypoten¬
sion induced by a bleed is also associated with an increase in Na+/H+
antiporter activity in skeletal muscle. This was discussed in Chapter 7.
This increase in Na+/H+ antiporter activity could be due to increased
sympathetic nerve activity affecting skeletal muscle during bleeding.
Somatic nerves to skeletal muscle contain sympathetic nerve fibres
(Siindlof and Gunnar Wallin, 1977), and it has been shown that hy¬
potension due to bleeding results in increased sympathetic neuronal dis¬
charge in these nerves (Green and Heffron, 1966). As there is also evi¬
dence of increased sympathetic neuronal activity in the SHR (Steikel et
al., 1986), increased Na+/H+ antiporter activity in the skeletal muscle of
SHRs most likely results from increased sympathetic neuronal activity
in skeletal muscle and in conjunction with the work presented in
Chapter 7 most likely occurs via increased P2-adrenoceptor
stimulation.
8.43 Changes in skeletal muscle metabolism after nifedipine
and bleeding.
The differences in acid responses during contraction are not due to
major differences in intracellular buffering from changes in PCr and
Pi5 since none of the stimuli used caused any changes in the utilization
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of skeletal muscle PCr or a difference in the change in Pi concentration
during contraction (Fig. 8.2). Although nifedipine and bleeding in¬
creased muscle lactate concentrations during contraction, differences in
lactate production do not explain the differences in cytosolic acid re¬
sponses to nifedipine and bleeding (Figs. 8.1b and 8.1c).
8.44 Differences in contractile responses between untreated
SHRs and WKY rats and the effects of nifedipine and bleed¬
ing.
Data presented in Chapter 5 has been reproduced here for the sake of
clarity (Figs. 8.3a and b), which shows that there is increased relaxation
after contraction in skeletal muscle in SHRs. This has also been shown
in subcutaneous arterioles obtained from patients with essential hyper¬
tension (Aalkjaer et al., 1989). This increased relaxation could be due to
increased bulk calcium extrusion from either increased Ca++-ATPase
activity in the sarcoplasmasic reticulum or increased Na+/Ca++
exchange (Carafoli, 1987) (as discussed in Chapter 5). Alternatively, it
could be due to an increased rate of repolarization secondary to
increased activity of Na+/K+-ATPase, which would be consistent with
the findings presented in Chapter 4 of increased in vivo Na+/K+-
ATPase activity in the skeletal muscle of SHRs.
The difference in relaxation after contraction between SHRs and WKY
rats was removed by nifedipine and bleeding (Figs. 3c-f). It is not pos¬
sible to be certain as to the underlying mechanism of this effect, but in¬
creased relaxation may be secondary to the hypotension caused by
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nifedipine and bleeding which would result in an increased sympathetic
discharge to skeletal muscle. As increased sympathetic activity has been
shown to increase Na+/K+-ATPase activity in skeletal muscle (Clausen,
1986) this may be the mechanism responsible for the increased rate of
muscle relaxation seen after nifedipine and bleeding.
CONCLUSIONS
In summary, this work shows that there is increased Na+/H+ antiporter
activity in vivo in the skeletal muscle of SHRs compared with WKY
rats and that this difference in antiporter activity can be removed by
blocking L-type calcium channels with nifedipine. This is evidence that
the increased activity of the Na+/H+ antiporter found in vivo in the
skeletal muscle of the SHR occurs in response to increased calcium
influx via L-type calcium channels. As increased calcium influx and
increased Na+/H+ antiporter activity have been shown to occur together
in other cells in hypertension, including vascular smooth muscle,
increased calcium influx via L-type calcium channels may also be the
mechanism responsible for the finding of increased Na+/H+ antiporter
activity in vascular smooth muscle. Furthermore, increased activation
of Na+/H+ antiporter due to increased calcium influx could occur





9.1 SUMMARY AND CONCLUSIONS
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In this thesis I have described new ways of studying ion transport in
vivo using nuclear magnetic resonance spectroscopy. These new tech¬
niques have been developed in order to study ion transport in hyper¬
tension and thus to determine whether or not in vitro abnormalities of
ion transport are present in vivo in hypertension. The main findings
from this work are listed in Table 9.1.
In Chapter 3 a new method of measuring absolute concentrations of the
87 87
cation rubidium in intact animals using Rb NMR ( Rubidium nu¬
clear magnetic resonance spectroscopy) was described. NMR to date,
has been used as a qualitative tool and previous methods of quantifica¬
tion have made assumptions about tissue volume. The method de¬
scribed in chapter 3 makes no assumptions regarding tissue volume and
overcomes problems of sample geometry, sample volume, tissue con¬
ductivity, coil tuning and amplifier gain. This method can be applied to
other NMR-visible nuclei and so could have many biological applica¬
tions and could be applied to man.
In Chapter 4 experiments were described which used the above method
to measure changes in tissue rubidium concentration with time during
the administration of rubidium salts, in the same animal. The aim of
this study was to assess the in vivo activity of sodium- and potassium-
activated adenosine triphosphatase (Na+/K+-ATPase) in the skeletal
muscle of the spontaneously hypertensive rat.
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These experiments showed that the rates of influx and efflux of rubid¬
ium are equally increased in skeletal muscle in SHRs in vivo.
Furthermore, the increases in the rates of rubidium influx and efflux
are balanced, so that there is no difference in the steady-state concen¬
trations of rubidium in either skeletal muscle or erythrocytes. These
findings suggest that in skeletal muscle and erythrocytes of SHRs there
is increased Na+/K+-ATPase activity and an increased rate of K+ ef¬
flux. Furthermore, SHRs had a faster redistribution of skeletal muscle
rubidium than WKYrats, and this could be explained by increased
Na+/K+-ATPase activity in tissues other than skeletal muscle and ery¬
throcytes in the SHR.
These in-vivo findings of increased Na+/K+-ATPase activity are
against the hypothesis that reduced Na+/K+-ATPase activity is respon¬
sible for increasing vascular tone in hypertension.
Na+/H+ antiporter activity in vitro has been found to be increased in
cells, including blood cells and vascular smooth muscle cells obtained
from both SHRs and patients with essential hypertension. In Chapters 5
and 6 experiments were described which showed that Na+/H+ an¬
tiporter activity is also increased in skeletal muscle of SHRs in vivo.
The increase in Na+/H+ antiporter activity found in the SHR in vivo is
more likely to be due to a change in the Km rather than to a change in
the Vmax of the antiporter, with a change in the Km of the antiporter
in hypertension from pH 7.16 to 7.33.
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It is also clear from this work that increased Na+/H+ antiporter activity
is found in association with increased relaxation of skeletal muscle
following contraction. This is consistent with the finding of increased
relaxation of vascular smooth muscle following contraction found in
arterioles obtained from patients with essential hypertension (Aalkjaer
et al., 1989). These findings are against the hypothesis that increased
Na+/H+ antiporter activity is responsible for increasing vascular
smooth muscle contractility in hypertension. Furthermore, in view of
the increased vascular relaxation, the cause of increased/normal vascu¬
lar tone in hypertension is likely to be due to increased activity of en¬
dogenous contractile agonists.
In Chapter 6 experiments were described which showed that the
changes in cytosolic acid following contraction were unaffected by
20% inhaled carbon dioxide or by 4,4'-di-isothiocyanostilbene-2,2'-
disulphonate (DIDS). This is evidence that bicarbonate exchange in
vivo is not important in the control of cytosolic acid concentrations
during skeletal muscle contraction in either SHRs or WKY rats.
Furthermore, no differences were found between adult SHRs and
WKY rats in regard to intrinsic buffering, resting intracellular and
extracellular pH, and resting intracellular and extracellular bicarbonate
concentrations. In addition, there was no evidence of a difference in
skeletal muscle bicarbonate/chloride exchange between SHRs and WKY
rats.
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These results show that SHRs and WKY rats have the same resting
lactate production, intrinsic buffering, bicarbonate/chloride exchange,
and arterial Pa C02. This explains the lack of difference in resting in¬
tracellular pH between the two types of rat and suggests that at rest dif¬
ferences in Na+/H+ antiporter activity due to a shift in Km of the an-
tiporter are too small to result in a difference in resting pH.
In Chapter 7 experiments were described which showed that ^-adreno¬
ceptor stimulation increases the activity of the Na+/H+ antiporter in vivo
in skeletal muscle. It was also shown that opening of the L-type calcium
channel is necessary for full activation of the Na+/H+ antiporter in skele¬
tal muscle in vivo. Furthermore, relaxation between twitches in skeletal
muscle is increased in conditions that would be expected to increase
cyclic-AMP and over the pH range 6.10 - 7.04 is not greatly affected by
changes in pH.
Bleeding also causes an increase in the activity of the Na+/H+ an¬
tiporter in vivo in skeletal muscle. This is most likely to be due to an
increase in sympathetic nerve outflow to skeletal muscle as a result of
hypotension. Thus, as part of the "fright and flight" reaction, this may
be one of the mechanisms by which animals under stress prepare their
skeletal muscle for exercise.
It is also clear from this work that the finding of increased Na+/H+ an¬
tiporter activity in the skeletal muscle of the spontaneously hyperten¬
sive rat is most likely to be due to increased sympathetic nervous ac¬
tivity and increased ^-adrenoceptor stimulation.
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In Chapter 8 experiments were described which showed that the in¬
crease in the activity of the Na+/H+ antiporter activity in vivo in the
skeletal muscle of SHRs compared with WKY rats can be removed by
blocking L-type calcium channels with nifedipine. This is evidence that
the increased activity of the Na+/H+ antiporter found in vivo in the
skeletal muscle of SHRs occurs in response to increased calcium influx
via L-type calcium channels. As increased calcium influx and increased
Na+/H+ antiporter activity have been shown to occur together in other
cells in hypertension, including vascular smooth muscle, increased cal¬
cium influx via L-type calcium channels may also be the mechanism re¬
sponsible for the finding of increased Na+/H+ antiporter activity in vas¬
cular smooth muscle. Furthermore, increased activation of Na+/H+ ex¬
change due to increased calcium influx could occur without any
increase in cytosolic calcium concentrations because of the high affinity
and capacity of sarcoplasmic-Ca++-ATPase.
In conclusion (see Table 9.1), I have described a series of experiments
which were designed to study ion transport in vivo in hypertension. I
have shown that ion transport abnormalities occur in vivo in hyper¬
tension and have provided evidence that both Na+/K+-ATPase activity
and Na+/H+ antiporter activity are increased in vivo in the SHR. I have
also shown that (^-adrenoceptor stimulation is the mechanism by
which Na+/H+ antiporter activity is increased in skeletal muscle and
that increased Na+/H+ antiporter activity in vivo in SHRs is due to in¬
creased calcium influx via L-type calcium channels. Furthermore, I
have provided evidence which may explain why SHRs have the same
steady-state concentrations of intracellular potassium ions,
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hydrogen ions and bicarbonate despite evidence for increased potas¬
sium and hydrogen ion flux. I have also shown that like vascular
smooth muscle, increased relaxation of skeletal muscle occurs follow¬
ing contraction and that increased relaxation following contraction is a
feature of both vascular smooth muscle and skeletal muscle in hyper¬
tension. I have argued that this increased relaxation occurs as a result
of increased Na+/K+-ATPase activity causing an increased rate of
membrane repolarization and that if increased vascular tone does occur
in hypertension it can only occur as a result of increased agonist-in¬
duced contraction.
In the final chapter of this thesis I will propose a new hypothesis that
explains my findings of ion transport abnormalities in SHRs in vivo
and the findings of others both in vitro and in vivo in blood cells and
other cells obtained from patients with essential hypertension. This hy¬
pothesis will also attempt to explain the central role of the kidney in
hypertension, the development of vascular hypertrophy, the develop¬
ment of increasing blood pressure with age and the finding of variable
renin activity in association with essential hypertension.
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Table 9.1 The main findings of the experiments presented in
Chapters 4-8 regarding in vivo ion transport in the skeletal muscle of
the spontaneously hypertensive rat compared with the Wistar-Kyoto
rat.
An equal increase in both rubidium (potassium) influx and efflux with the
same steady state rubidium (potassium) concentrations
Increased Na+/K+-ATPase activity
Increased Na+/H+ antiporter activity
Blocking L-type calcium channels removes the increase in Na+/H+
antiporter activity
No differences in resting pH, intrinsic buffering or bicarbonate handling
page 163
Chapter ten





Over the last few years there have been numerous reports of abnormal
handling of cations by various cells obtained from patients with essen¬
tial hypertension and from hypertensive rats. In this chapter I will pre¬
sent a hypothesis which attempts to explain the mechanism responsible
for these abnormalities and the significance of these changes in cation
handling to the development of genetic hypertension in rat and man.
The hypothesis that will be presented incorporates other published hy¬
potheses, namely the nephron hypothesis of Sealey et al. (1988) and the
hypothesis of Lever (1986) that vascular smooth muscle hypertrophy is
linked to an effect of angiotensin II. This hypothesis also explains other
features of hypertension, including saline-induced natriuresis, variable
plasma renin activities and differing salt sensitivities of patients with
essential hypertension, and the tendency of blood pressure to increase
with advancing age.
10.11 Abnormalities of ion transport in vitro in hyperten¬
sion
10.111 Intracellular ion concentrations
There have been numerous reports of altered concentrations of intra¬
cellular cations in association with hypertension. Intracellular sodium
concentrations have been reported to be consistently increased in leu¬
cocytes obtained from patients with essential hypertension (Edmondson
et al., 1975; Ambrosioni et al., 1981; Heagerty et al., 1982). However,
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in erythrocytes intracellular sodium concentrations have been reported
to be either increased (Clegg et. al., 1982; Cole, 1983) or normal
(Canessa et al., 1980; Garay et al., 1980) (for a review see Swales,
1982), although it has been argued that the intracellular sodium con¬
centration as a mean of all studies is significantly increased (Hilton,
1986). However, there is growing evidence that much of what was
thought to be intracellular sodium is extracellular, attached to the out¬
side of the cell membrane, resulting in an apparent increase in intracel¬
lular sodium, and that intracellular sodium concentrations are probably
normal in essential hypertension (Simon, 1989; Simon, 1990).
In contrast, intracellular potassium concentrations, which are much
higher than intracellular sodium concentrations, and so less susceptible
to measurement error, have not been found to be different in cells ob¬
tained from either patients with essential hypertension or sponta¬
neously hypertensive rats (SHRs) (Boon et al., 1986; Aalkjaer et al.,
1985). This lack of difference in steady-state potassium concentrations
occurs despite evidence that the rates of potassium fluxes into and out
of cells are increased in genetic hypertension (Postnov et al., 1976;
Orlov et al., 1989; see Chapter 4).
Small increases in free cytosolic calcium concentration have been re¬
ported in some cells (Eme et al., 1984; Astaire et al., 1989; Lindner et
al., 1987), but this is not a uniform finding (Nabika et al., 1985;
Bukoski, 1990; Pritchard et al., 1989). However, total cell calcium has
been shown to be consistently increased in hypertension (Postnov and
Orlov, 1985; Tobian and Chesley, 1966; Speiker et al., 1988). Total
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cellular calcium increases with age (Bhalla et al., 1978; Fleckenstein et
al., 1986) as it does in hypertension, but the process of calcium seques¬
tration is accelerated in hypertension (Speiker et al., 1988; Bruschi et
al., 1985).
10.112 Abnormalities of ion transport systems
Numerous abnormalities have been described in a variety of ion trans¬
port systems in hypertension, including Na+/K+-ATPase (the Na+/K+
pump), Na+/Na+ (Na+/Li+) exchange, the Na+/H+ antiporter, L-type
calcium channels, sarcolemmal Ca++-ATPase, and Na+/K+/CT co-
transport.
Na+/K+ pump activity has been proposed to be reduced in leucocytes
(Edmondson et al., 1975; Poston et al., 1981; Heagerty et al., 1982).
However, measurements of Na+/K+ pump activity in these experiments
have relied on measurements of increased intracellular sodium concen¬
trations and measurements of fluxes derived there from, and as men¬
tioned above there is now some doubt that the intracellular sodium
concentration really is increased in essential hypertension. This casts
doubt on the suggestion that Na+/K+ pump activity is reduced in hy¬
pertension. Furthermore, there is other in vitro evidence that Na+/K+
pump activity is increased (Simon et al., 1987) in essential hyperten¬
sion and in leucocytes of borderline hypertensives (Nielson et al.,
1988). Confirmatory evidence of increased Na+/K+pump activity
comes from in-vivo studies (see next section). It should be noted that
increased Na+/K+ pump activity in these circumstances would not
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necessarily imply that the intracellular sodium concentration should be
reduced, since there is also evidence of increased sodium influx via the
Na+/H+ antiport (see below).
In contrast to the confusion about the nature of the changes in Na+/K+
pump activity in essential hypertension, the changes which have been
described in other transport systems in a variety of tissues have mostly
been consistent. For example, there is consistent in vitro and ex vivo
evidence of increases in the activities of the Na+/Na+ (Na+/Li+) coun-
tertransport (Canessa et al., 1980; Canessa et ah, 1988), the Na+/H+
antiport (Livne et al., 1987; Kuriyama and Aviv, 1987, Izzard and
Heagerty, 1989; for review see Aalkjaer, 1990), increased calcium in¬
flux via L-type calcium channels (Rusch and Hermsmeyer, 1988; for
reviews see Postnov and Orlov, 1985 and Dominiczak and Bohr,
1990), and reduced sarcolemmal Ca++-ATPase activity (for reviews
see Postnov and Orlov, 1985 and Dominiczak and Bohr, 1990). Some
of these abnormalities have been confirmed in vivo (see below). The
co-transport of Na+/K+/CF has been shown to be reduced at least in
some cells, but the findings are inconsistent (for a review see
Chipperfield, 1986).
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10.12 Abnormalities of ion transport in vivo in hypertension
There are many difficulties in the techniques which are used to define
ion transport abnormalities in vitro (Poston et al., 1982; Duhm et al.,
1982; Boon et al., 1986; Simon, 1990). It has therefore been proposed
that inconsistencies in the reports of in vitro ion transport abnormali¬
ties in hypertension may result from differences in the experimental
conditions used in different laboratories (Swales, 1982; Boon et al.,
1986; Neilsen et al., 1988).
10.121 Cellular studies
Problems with in vitro methods of studying cation transport have
prompted the development over the last few years of methods of
studying cation transport in vivo. These methods have been based on
the principle that certain ions which are not found in high concentra¬
tions in the body can be used as markers for endogenous ions, for ex¬
ample rubidium for potassium (Boon et al., 1986) and lithium for
sodium (Brearley et al., 1988). In these experiments animals or man
are given an amount of the relevent ion of interest and blood samples
taken at various times after cation administration. The concentration of
the cation in plasma and erythrocytes are then determined in vitro.
This enables an indirect estimate of cation handling in vivo. In essential
hypertension these techniques have shown that there is increased
Na+/K+-ATPase activity in erythrocytes and an increase in the rate of
potassium absorption (Boon et al., 1986). In addition, there is an in-
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crease in the activity of the Na+/Li+ countertransport in erythrocytes,
which is associated with a change in either the stoichiometry or
co-operativity of the transporter (Brearley et al., 1988).
10.122 Intact tissue studies
The work presented in the preceding chapters of this thesis has used
nuclear magnetic resonance spectroscopy in new ways to study ion
transport non-invasively and entirely in vivo (see Chapters 2-8). Part
of this work has also used the concept that an exogenous ion
(rubidium) can act as a marker of the way an endogenous ion
(potassium) is handled in vivo. The techniques described in earlier
chapters of this thesis have been used to measure transmembrane fluxes
of rubidium and hydrogen ions in the skeletal muscle of intact sponta¬
neously hypertensive rats. This work has led me to formulate a new
hypothesis to explain why there are abnormalities of ion transport
systems in hypertension.
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10.2 PREVIOUS HYPOTHESES RELATING ABNORM¬
ALITIES OF ION TRANSPORT TO THE PATHOPHYS¬
IOLOGY OF HYPERTENSION
Numerous hypotheses have been proposed to explain some of the ion
transport abnormalities found in hypertension.
10.21 The hypothesis of inhibition of Na+/K + -ATPase
activity
DeWardener and Macgregor (de Wardener and MacGregor, 1980)
adapted a hypothesis of Dahl and proposed that a circulating inhibitor
of Na+/K+-ATPase was responsible for increasing vascular tone in hy¬
pertension via an alteration of Na+/Ca++ exchange in vascular smooth
muscle, based on a mechanism first outlined by Blaustein (Blaustein,
1977). Subsequently many groups have identified Na+/K+-ATPase in¬
hibitory activity or digital is-like immunoreactivity in essential hyper¬
tension (for reviews see de Wardener and Clarkson, 1985 and Poston,
1987). However, the finding of increased rather than decreased
Na+/K+-ATPase activity mentioned above is incompatible with this hy¬
pothesis. Furthermore, it has been difficult to find a mechanism which
links inhibition of Na+/K+-ATPase activity to the development of an
increase in blood pressure (Aronson, 1984; Casteels et al., 1985;
Postnov and Orlov, 1985).
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10.22 The hypothesis that generalized membrane abnormal¬
ity is responsible for ion transport abnormalities in hyper¬
tension
It has been shown that the membranes of different cells obtained from
patients with essential hypertension are abnormal, with evidence of re¬
duced membrane fluidity and calcium binding (for reviews see Swales,
1982 and Postnov and Orlov, 1985). The finding of an abnormal cell
membrane in association with multiple abnormalities of membrane ion
transport has led to a major alternative proposal to that of De
Wardener & MacGregor (1980) that an intrinsic defect of the cell
membrane is responsible for the abnormalities in ion transport found
in association with hypertension.(Swales, 1982; Postnov and Orlov,
1985; Postnov, 1990; Dominiczak and Bohr, 1990). For example, this
has been proposed to be the mechanism for the abnormalities in the
Na+/H+ antiport which are found in hypertension (Canessa, 1988).
However, I have presented work in this thesis which shows that the in¬
crease in Na+/H+ antiport activity found in SHRs in vivo can be re¬
moved by blocking L-type calcium channels (see Chapter 8), suggest¬
ing that the antiporter is altered in hypertension by an interaction with
calcium and not as a result of an interaction with an abnormal mem¬
brane. In addition, as will be outlined later, the findings of increased
calcium influx and reduced sarcolemmal Ca++-ATPase activity in
essential hypertension, both of which have been considered to be due to
an intrinsic membrane abnormality (Postnov and Orlov, 1985;
Postnov, 1990; Dominiczak and Bohr, 1990) can result from increased
agonist stimulation of the cell. Futhermore, the minor changes in
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membrane composition found in essential hypertension are unlikely to
be responsible for the finding of increased Na+/K+pump activity, as
major changes in membrane composition induced artificially are re¬
quired before Na+/K+-ATPase activity is altered (Skou, 1975) and any
change in membrane composition is likely to lead to reduced rather
than increased Na+/K+pump activity (for review see Swales, 1982).
Finally, it is equally likely that the ion transport abnormalities found in
association with hypertension cause the changes in the composition of
cell membranes, because of alterations in transcriptional, translational
and post-translational events in the cell (for a review see Geering,
1986).
10.23 The hypothesis that renal ischaemia affects sodium
reabsorption
A hypothesis has been proposed (Sealey et al., 1988) which attempts to
explain the paradox that there is on the one hand increased sodium re-
absorption from the proximal tubule of the kidney in essential hyper¬
tension but on the other hand low or normal plasma volume and blood
volume and an exaggerated natriuretic response to saline infusion. This
hypothesis proposes that the kidney, which has been shown to be con¬
sistently implicated in the pathogenesis of genetic hypertension (for a
review see de Wardener, 1990a and 1990b), has two populations of
nephrons:
(a) ischaemic nephrons, which produce excessive renin and re¬
sult in increased angiotensin II concentrations and hence sodium
retention;
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(b) normal nephrons, which under the influence of the resultant
increased angiotensin II concentrations produce less renin than
normal.
Under these circumstances the extent to which net tubular sodium re-
absorption occurs will depend on the balance between the effect of an¬
giotensin II on ischaemic and normal tubules and the perfusion pres¬
sure affecting each nephron. When the pressure increases or there is a
saline load the effects on the normal nephrons predominate and a na-
triuresis occurs.
Sealey et al. provide a great deal of evidence to support their hypothe¬
sis, and it is relevant to the hypothesis I will propose below.
10.24 The hypothesis that changes in Na+/H+ antiport activ¬
ity are associated with vascular smooth muscle hypertrophy
The observations that Na+/H+ antiport activity increases after exposure
to mitogenic stimuli and that Na+/H+ antiport activity is increased in
hypertension have led to the hypothesis that vascular smooth muscle
hypertrophy in hypertension is related to increased Na+/H+ exchange
(Lever, 1986). This view is supported by the observation that both
angiotensin II and noradrenaline increase the activity of the Na+/H+
antiport (Aalkjasr and Cragoe, 1988; Berk et al., 1987a) and also cause
vascular smooth muscle cell growth in culture (Campbell-Boswell and
Robertson, 1981; Blaes and Boissel, 1983). This hypothesis is also rel¬
evant to the hypothesis I will propose below.
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Any hypothesis which links abnormalities in ion transport with the
pathophysiology of hypertension should explain why there are ion
transport abnormalities in essential hypertension and should also ex¬
plain the following observations:
Differences between plasma renin activities in different sub¬
groups of hypertensive patients, who may have low, normal, or
high plasma renin activity (Brunner et al., 1972), in association
with differences in salt-sensitivity from patient to patient, which
to some extent correlate with differences in renin (Laragh,
1973; Case et ah, 1978).
The paradox that there is on the one hand increased sodium re-
absorption from the proximal tubules of the kidney both in pa¬
tients with essential hypertension (Weber, 1986) and in animals
with genetic hypertension (Kato et ah, 1986) and on the other a
low or normal plasma volume and blood volume (Tarazi et ah,
1968; Dustan et ah, 1973) and an exaggerated natriuretic re¬
sponse to infusion of saline (Farnsworth, 1946; Cottier et ah,
1958; Papper et ah, 1960).
The development of abnormalities of ion transport before the
development of hypertension (Henningsen et ah, 1979; Woods et
ah, 1981; Neilsen et ah, 1988).
Chapter 10 page 175
The hypertrophy of vascular smooth muscle in hypertension,
which is found in association with abnormalities of ion transport
(Lever, 1986; Postnov, 1990).
The natural tendency of blood pressure to increase with advanc¬
ing age (James et al., 1986).
This hypothesis proposes that the vascular hypertrophy and the abnor¬
malities of ion transport which are found in essential hypertension are
primarily due to patchy hypoperfusion of nephrons, which in turn
leads to increased secretion of angiotensin II. This is as proposed by
Sealey et al. (see above). Angiotensin II, in association with angiotensin
II-induced increased sympathetic nervous activity (Mathias, 1987,
Matsukawa et al., 1988; Fink et al., 1986; Webb et al., 1988), then
causes both vascular smooth muscle hypertrophy and abnormalities of
ion transport. This hypothesis is illustrated in outline in Fig. 10.1, and
explains all of the above features of hypertension. The details of this
hypothesis are shown in Figs. 10.2-4.
10.31 Alterations of ion transport systems in response to
angiotensin II and/or noradrenaline
Fig. 10.2(a) and (b) shows the sequence of events that I propose occur
after stimulation of vascular smooth muscle cells by angiotensin II.
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Patchy nephron hypoperfusion
Increased secretion of renin by ischaemic nephrons
(plasma renin activity inappropriately high)
Increased secretion of angiotensin II






Fig. 10.1 Schematic diagram outlining the effects of partial renal is-
chaemia.
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10.311 Membrane depolarization and a tendency to increase cell
volume
The first effect of angiotensin II and also noradrenaline (as mentioned
above) is membrane depolarization in association with activation of the
inositol phosphate pathway and the opening of L-type calcium chan¬
nels, resulting in increased influx of calcium ( Berk et al., 1987b;
Allen et al., 1988). In chapter 8 it was argued that this increase in cal¬
cium influx would lead to a local increase in calcium concentration at
the cell membrane (Carafoli, 1988) without necessarily increasing the
cytosolic concentration of free calcium. This local increase in mem¬
brane calcium, in conjunction with activated protein kinase C (for a
review see Grinstein et al., 1986) increases the activity of the Na+/H+
antiport by altering its affinity for H+ ions and so efflux of H+ ions out
of the cell becomes more efficient. This increase in Na+/H+ antiporter
activity is necessary for homoeostatic control of intracellular pH, since
there is increased production of acid resulting from ATP hydrolysis
when cells are stimulated to contract under the influence of angiotensin
II or noradrenaline. This intracellular acidosis would reduce the effec¬
tive intracellular concentration of bicarbonate, and result in an influx
of bicarbonate via a sodium-dependent bicarbonate/chloride exchange
(Cala and Grinstein, 1988). This is illustrated in Fig. 10.2a.
If this process continued unabated it would result in sustained mem¬
brane depolarization and an increase in the intracellular concentration
of sodium and thus cell swelling. However, this does not occur, since
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10.312 Membrane repolarization and a tendency to decrease cell
volume
In response to the tendency of the cell to swell, as described above,
there will be a counter-regulatory decrease in cell volume due to in¬
creased potassium efflux, resulting from the opening of volume-sensi¬
tive potassium channels (for a review see Hoffman and Simonsen
1989). Since potassium efflux will be accompanied by chloride efflux
via K+/C1" co-transport, the intracellular chloride concentration would
tend to fall. However, this would be opposed by chloride influx via a
sodium-independent bicarbonate/chloride exchange (Cala and
Grinstein, 1988), which would also oppose the bicarbonate influx de¬
scribed above. This is illustrated in Fig. 10.2b.
The net effect of this combination of ion movements across the cell
membrane would be an increase in the intracellular sodium concentra¬
tion and a reduction in the intracellular potassium concentration. These
changes would activate the Na+/K+-ATPase (for a review see Schwartz
et al., 1975) (Fig. 10.2b), in turn restoring the concentrations of
sodium and potassium to normal.
Thus, the multiple findings of increased fluxes of Na+ ions and K+ ions
in essential hypertension, in association with normal intracellular con¬
centrations of sodium and potassium, can be explained by a sequence of
linkage of different ion transporters which are involved in the regula¬
tion of pH, cell volume, and intracellular ion concentrations, all result¬
ing from a physiological response of the cell to stimulation by agonists
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such as angiotensin II and noradrenaline. These events are consistent
with the in-vivo ion transport abnormalities discussed above in essen¬
tial hypertension (Boon et al., 1986) and also those presented in earlier
chapters of this thesis namely increased Na+/H+ antiport activity in the
SHR (see Chapters 5 and 6), which can be removed by blocking cal¬
cium influx via L-type calcium channels (see Chapter 8), increased
potassium (mbidium) influx via the Na+/K+-ATPase (see Chapter 4),
increased potassium (rubidium) efflux in SHRs (see Chapter 4), the
same intracellular steady-state concentration of potassium (rubidium)
despite increased influx and efflux in SHRs (see Chapter 4), and the
same steady-state concentration of intracellular hydrogen ions and bi¬
carbonate in the SHR (see Chapter 5 and 6). Finally, because it has
been suggested that altered Na+/H+ antiporter activity is linked to al¬
tered Na+/Li+ countertransport in essential hypertension (Canessa,
1988), increased agonist stimulation of the cell resulting in this se¬
quence could also explain the finding of increased Na+/Li+ counter-
transport in patients with essential hypertension in vivo (Brearley et
al., 1990; Brearley et al., 1990).
At this juncture two points should be stressed. First, that despite these
increases in the activities of numerous ion transport systems in hyper¬
tension, steady-state intracellular concentrations of potassium
(rubidium) (see Chapter 4), hydrogen ions (see Chapters 5 and 6) and
bicarbonate (see Chapter 6) are not different, since the various changes
in fluxes tend to oppose one another. Second, that these changes in ion
transport would precede the development of clinical hypertension,
which I believe is more likely to be dependent on vascular smooth
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muscle remodelling and hypertrophy, as others have previously
suggested (Folkow et al., 1973; Folkow et al., 1982; Lever, 1986;
Struyker Boudier et al., 1990). This is consistent with the observation
that the normotensive first-degree relatives of patients with essential
hypertension, who are at risk of developing hypertension in later
years, have the same ion transport abnormalities (Henningsen et al.,
1979; Woods et al., 1981; Neilsen et al., 1988).
In the next section I propose that vascular smooth muscle hypertrophy
occurs in response to long-term agonist stimulation, in contrast to the
changes in ion transport, which can occur more quickly. However, it is
likely that the two processes are closely linked.
10.32 Vascular smooth muscle hypertrophy in response to
angiotensin II and noradrenaline
I propose that vascular smooth muscle hypertrophy in hypertension re¬
sults from a gradual accumulation of calcium in the sarcoplasmic
reticulum and endoplasmic reticulum of the vascular smooth muscle
cell over a number of years, due to a prolonged increase in agonist
activity by for example angiotensin II and also noradrenaline. The
proposed mechanism for this effect is illustrated in Fig. 10.3.
Fig. 10.3 shows the changes in calcium disposition which I propose are
responsible for gradual hypertrophy of vascular smooth muscle in hy¬
pertension. There is reduced efflux of calcium because of reduced
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Fig. 10.3 A diagram of the changes in vascular smooth muscle cell
handling of calcium resulting from chronic angiotensin
II/noradrenaline stimulation.
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activity of sarcolemmal Ca++-ATPase (for reviews see Postnov and
Orlov, 1985 and Dominiczak and Bohr, 1990); and an increased rate
of calcium influx (Rusch and Hermsmeyer, 1988; for reviews see
Postnov and Orlov, 1985 and Dominiczak and Bohr, 1990). Both of
these fluxes occur via the plasma membrane. If these two alterations in
fluxes continued unopposed the cytosolic calcium concentration would
rise. However, increased flux of calcium from the cytosol into the
sarcoplasmic reticulum (for a review see Carafoli, 1987) would tend to
oppose an increase in the cytosolic concentration of calcium, keeping it
at or near normal, while sarcoplasmic reticular calcium (and hence
sequestered cell calcium) would increase. Reports of increased
sequestered cell calcium in hypertension are consistent with this
(Tobian and Chesley, 1966; Postnov and Orlov, 1985; Speiker et al.,
1988).
Increased accumulation of calcium in the sarcoplasmic reticulum and
endoplasmic reticulum of vascular smooth muscle will then increase
protein synthesis (Brostrom and Brostrom, 1990) and cause cellular
hyperplasia (Geering, 1986). Thus, this gradual accumulation of cal¬
cium will result in vascular remodelling and hypertrophy, establishing
increased peripheral resistance and increased blood pressure.
There is evidence which supports the above sequence of events.
Whereas it has been shown that acute stimulation of the vascular
smooth muscle cells with angiotensin II and nordrenaline results in net
efflux of calcium and a reduction in total cell calcium (Berk et al.,
1987b; Hatori et ah, 1987; for a review see Exton, 1985), there is evi¬
dence that prolonged stimulation with both angiotensin II and
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noradrenaline produces net influx of calcium and an increase in the
total cell calcium (Prpic et al., 1984; Joseph et al., 1985; for reviews
see Exton, 1985 and Exton, 1988). This results because prolonged
stimulation with both angiotensin II and noradrenaline increases
calcium influx into the cell via increased opening of L-type calcium
channels (Allen et al., 1988; Exton, 1988) and reduces calcium efflux
by reducing the activity of sarcolemmal Ca++-ATPase (Prpic et al.,
1984; Exton, 1988).
It should be noted that both increased calcium influx via L-type chan¬
nels and decreased activity of sarcolemmal Ca++-ATPase are consistent
findings in hypertension which have to date been explained by an in¬
trinsic membrane abnormality (see above). However, it is clear that an
alternative explanation for these findings is chronic agonist stimulation
of the vascular smooth muscle cell by angiotensin II and noradrenaline.
10.33 Reasons for altered renal sodium handling in hyper¬
tension
As outlined above the hypothesis of Sealey et al.(1988) states that the
kidney in hypertension has two populations of nephrons, hypoperfused
nephrons, which produce excessive renin and result in increased an¬
giotensin II concentrations and hence sodium retention, and normal
nephrons, which under the influence of the resultant increase in an¬
giotensin II concentrations produce less renin than normal. Whether or
not there is a tendency towards sodium retention and volume expansion
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then depends on the balance between sodium retention by hypoperfused
nephrons and sodium loss by normal nephrons.
Based on this hypothesis and in conjunction with my own suggestion
that long-term stimulation by angiotensin II and/or noradrenaline will
increase sequestered cell calcium, I propose a sequence of events which
I believe provides an explanation for the apparent paradox that salt
retention (Weber, 1986; Kato et al., 1986) co-exists in hypertension
with an exaggerated natriuretic response to infusion of saline
(Farnsworth, 1946; Cottier et al., 1958; Papper et al., 1960). A
schematic representation of the proposed sequence is shown in Figures
10.4a and b.
Increased circulating concentrations of angiotensin II will both in¬
crease sodium reabsorption in the proximal renal tubule (Harris and
Navar, 1985; Schuster, 1986) and cause increased release of aldos¬
terone (Quin and Williams, 1988). Both of these effects will cause
sodium retention in all nephrons, whether hypoperfused or not
(Figure 4a). This would lead to volume expansion which would how¬
ever be opposed by the secretion of atrial natriuretic factor (ANF) (for
a review see Ballermann and Brenner, 1985) and possibly also the pu¬
tative inhibitor of Na+/K+-ATPase (for reviews see de Wardener and
Clarkson 1985 and Poston, 1987). It should be noted that these actions
of angiotensin II in causing sodium retention are both short-term and
long-term actions.
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In parallel with these effects, I believe (Figures 10.3 and 10.4b) that
angiotensin II and noradrenaline increases sequestered intracellular
calcium concentrations and that this results not only in vascular smooth
muscle hypertrophy (as described above) but also in a further reduc¬
tion in the secretion of renin in normal glomeruli through accumula¬
tion of calcium in the juxtaglomerular cells (for a review see Fray et
al., 1987). This combination of increased pressure and reduced renin
from normal glomeruli results in increased sodium loss from the nor¬
mal nephrons (i.e. a pressure natriuresis). This in turn leads to volume
reduction, which will switch off the secretion of ANF and the putative
inhibitor of Na+/K+-ATPase. This effect would also explain the saline-
induced natriuresis of hypertension, because saline load would cause a
further increase in the sodium load in the nephron. Nevertheless, hy-
poperfused nephrons will at the same time continue to drive the pro¬
duction of angiotensin II (Figure 10.4a), whose production will not be
switched off. Thus, the overall balance between the effects of hypoper-
fused nephrons and the effect of normal nephrons will determine
sodium and volume homoeostasis in hypertension.
10.34 Reasons for different renin subgroups and degrees of
salt sensitivity in essential hypertension
As the secretion of renin and the formation of angiotensin II should be
completely inhibited with an increase in renal perfusion pressure
(Tobian, 1960; Vander, 1967) it follows that in established hyperten¬
sion even when the plasma renin activity is low there is inappropriately
high renin secretion. Thus, in all forms of hypertension there is de-
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tectable activity of renin in the plasma because of nephron hypoperfu¬
sion. I therefore propose that the different plasma renin activities in
hypertension relate to different grades of nephron hypoperfusion.
From this one would predict that in hypertension with low renin activ¬
ity the blood pressure would be more dependent on volume expansion
(i.e. relatively more salt-sensitive) than it is on renin and angiotensin
II, while in hypertension with high renin activity the blood pressure
would be more dependent on renin and angiotensin II (i.e. relatively
less salt-sensitive). This is a recognized association (Laragh, 1973;
Case et al., 1978).
With an increasing degree of nephron hypoperfusion and increased
renin production one might expect increased sodium reabsorption and
volume expansion (Figure 4a). However, I propose that this does not
happen, because the increased blood pressure increases the perfusion
pressure of normal glomeruli and increases natriuresis (Figure 10.4b),
which therefore predominates over sodium retention.
With worsening ischaemia there is further sodium loss and plasma vol¬
ume reduction, which in turn causes a further reduction in blood flow
to the kidney, leading to a further increase in renin and a upward spi¬
ral of increasing blood pressure. I believe that this happens in the ex¬
treme case of malignant hypertension, in which very high concentra¬
tions of renin are associated with sodium loss and plasma volume re¬




(b) Increased angiotensin II












Na / K pump inhibitor f
ANF and putative
+ +
Na / K pump inhibitor I
Fig. 10.4 A schematic outline of (a) the sodium-retaining effects of in¬
creased angiotensin II stimulation and (b) the pressure natriuresis ef¬
fect of prolonged angiotensin II stimulation.
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Increases in total calcium have been reported to occur with increasing
age, and this may explain the findings of vascular smooth muscle hy¬
pertrophy and the development of increased blood pressure with in¬
creasing age (James et al., 1986), as discussed above. This could result
from angiotensin II and/or noradrenaline stimulation over many years.
These effects would also explain the observation of a reduction in
plasma renin activity with increasing age (for a review see Swales,
1989), since this would result from a combination of a reduced num¬
ber of nephrons and the renin-lowering effects of an increased total
intracellular calcium (Fray et al., 1987). One would also predict that
blood pressure in the elderly would be relatively sensitive to the effects
of salt.
10.4 SUMMARY AND PREDICTIONS
I have outlined above the observations which I believe should be ex¬
plained by a hypothesis which links abnormalities in ion transport with
the pathophysiology of hypertension. The above hypothesis fulfils this
criterion, since it provides an explanation for the ion transport abnor¬
malities found in genetic hypertension in animals and in man and in
addition it explains:
1. The differences between plasma renin activities in different sub¬
groups of hypertensive patients in association with differences in salt-
sensitivity from patient to patient.
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2. The paradox that there is on the one hand increased sodium reab-
sorption from the proximal tubules of the kidney in hypertension and
on the other hand low or normal plasma and blood volumes and an ex¬
aggerated natriuretic response to infusion of saline and to increased
pressure.
3. The development of abnormalities of ion transport before the devel¬
opment of hypertension.
4. The hypertrophy of vascular smooth muscle in hypertension.
5. The tendency for blood pressure to increase with advancing age.
The multiple ion transport abnormalities found in genetic hypertension
can be explained by chronic stimulation by agonists such as angiotensin
II and noradrenaline, without the need to propose that an abnormal cell
membrane is responsible. Furthermore, as discussed above, the
changes in the composition of the membrane could be caused by these
ion transport abnormalities.
Certain predictions arise from this hypothesis. For example, it is likely
that different ion transport abnormalities and volume status will be
found at different times during the development of hypertension. One
would also predict a change in the number of both angiotensin II re¬
ceptors and possibly at-adrenoceptors with the development of hyper¬
tension, in keeping with the changes that would be expected from
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chronic stimulation of these receptors (Colucci and Alexander, 1986;
for a review see Exton, 1988). However, the negative effect this would
have on vascular responsiveness would have to be balanced against the
positive effect of angonist-induced calcium loading of the vascular
smooth muscle cell. It is also clear that certain drugs would be more
likely to be effective in certain sub-types of hypertension. Finally, if
this hypothesis is correct essential hypertension is a potentially re¬
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